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 Nutrition directly shapes phenotype and genetic health, therefore playing a central 
role in determining health outcomes and disease trajectories. Chronic health problems and 
nutritional deficits have been rapidly escalating globally as nutritional deficiencies 
continue to accelerate the onset of illness and suffering. Vitamin D deficiency for example 
is causative in many pathophysiological disease and metabolic conditions while correction 
of deficient levels is known to treat cancer and reduce cardio-metabolic risks. Despite the 
bio-social origins and explicit connections between nutrition and health, explanations 
remain contentious at best. Enhanced diagnostic and nutritional epidemiological 
approaches are required in order to delineate any ambiguities. Serving as a follow up study 
by biological anthropologists into notable longevity among the Kansas Mennonite, The 
Kansas Nutrition Project (KNP) explores the effects of nutrition and genetics on chronic 
health. Nutrients and their cellular receptors interact with genes coding for hormones, 
particularly adiponectin and leptin. Recent studies show vitamin D influences normal 
levels of adiponectin and leptin both in healthy and unhealthy populations with research 
benefiting from cross-cultural and population level studies. Mennonite populations of 
Kansas have experienced several instances of differential bottlenecks and founder effects 
during their migration histories across Europe and the Americas while maintaining cultural 
and religious independence. The reliability of working within population isolates in 
anthropological and epidemiological research is well supported, with linear relationships 
increasing with increasing population homogeneity. Combining measures of nutritional 
intake and diagnostic biomarkers, this thesis investigates the relationships between 
nutritional intake and measures of adiponectin and leptin within a population of semi-
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isolate Kansas Mennonite. Using data from the KNP, I construct sex-specific multivariate 
models of nutritional intake and hormone variation using anthropological and 
epidemiological rationale. Investigations include the relationships between nutritional 
intake, adipose traits and micronutrient intake on circulating hormone phenotypes. 
Operating within a sex-specific and nutrigenetic framework, I predict lipophilic nutrients 
like vitamins A, D, E and K may play significant roles in the variation of adiponectin and 
leptin within this population of Mennonite. Results show statistically significant (p < 0.05) 
variation between females and males in almost all categories of variables including 
anthropometrics, blood lipids, nutrient intake and hormone variation in this population of 
semi-isolated Kansas Mennonite. Vitamin D intake was significant for adiponectin and 
leptin levels in men but not women, while folate was significant in leptin level in women 
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This thesis attempts to highlight the cultural and biological factors shared between 
nutrition and chronic disease by examining the associations between nutritional intake and 
concentrations of adipokine of clinical significance in a sex-stratified semi-isolate population of 
Kansas Mennonite. It examines the relationships between nutritional intake and hormone levels 
for possible clinical applications. While both anthropology and epidemiology contribute insight 
and enhanced understanding of human health and disease, they both have short comings in their 
structures (Janes, Stall and Gifford, 1987; Trostle, 2005). Anthropology and epidemiology can 
learn from each other and be combined to enhance outcome efficacy and application (Béhague et 
al., 2008; Ayeni, 2008). Human nutrition has relied upon epidemiological and interventional 
studies to understand the mechanism between food and health. A cross-cultural perspective using 
anthropological techniques within a semi-isolate population will benefit and advance ultimate 
understandings of diet and disease.  
 
Conceptual Model: Nutritional Phenotype and Epidemiology  
 Interactions between nutrition and genetics may be epidemiologically studied with the 
collection of biological samples (Bingham, 2002). The mechanisms underlying individual health 
status can be complex when asking about nutritional effects. Voruganti et al. (2013) find that diet 
shapes chronic disease and mitigates the effects of genetics on disease traits in a population of 
baboon (Papio) (Higgins et al., 2010; McCurdy et al., 2009). These diet-gene interactions are 
paralleled in humans as diet actively shapes biological traits and genetic expression (Johnson and 
Belshaw, 2014; Mead, 2007). The nutritional phenotype is a varying function of diet, integrating 




or wellness and is the quantitative indication of the paths by which genes and environment 
exert health effects (Mosher, 2012) (see figure 1). These processes are individual and 
collectively spatio-temporally relative, predicated by social and biological factors as sex, 
age, developmental state, stress, health status and timing of environmental exposure 
(Mosher, 2012). More focus and work is needed on larger populations and different 
ethnicities to resolve these controversies. Conceptualizing a nutritional phenotype gives 
form and substance to the recognized future of nutritional science in confronting disease 
and health and for this there is a need for valid, reliable measures of the nutritional 




Figure 1. Theoretical illustration of the nutritional phenotype. Consideration for the 
nutritional causes of complex diseases must grow and better methods for studying human 
health and nutrition are needed. Conceptualization of a nutritional phenotype may help in 
those goals (adapted from Zeisel et al., 2005 pg. 7). 
 
 Genetic epidemiology is similar to traditional epidemiology in its efforts to 
understand the spread, containment and potential removal of a disease within a given 
community also using principles and methods from population genetics (Khoury et al., 
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1993; Morton et al., 1967). While diseases and disease traits are of interest they are not of 
exclusive focus in genetic epidemiology which also examines anthropometric and 
behavioral factors in disease etiology (DeWan, 2010; Rao, 1983). Where human genetics 
focuses on classic concepts of Mendelian diseases, diseases with a single gene culprit, 
genetic epidemiology examines complex diseases involving many genes such as chronic 
disease. These complex diseases manifest in many different constellations of symptoms 
and pathologies. Understanding the genetic determinants of chronic disease requires 
working within populations of similar genetics in order to make population level claims 
using any genetic results. For this reason, working within geographic, cultural and 
linguistic isolates is far more ideal (Hatzikotoulas et al., 2014; Kristiansson et al., 2008; 
Peltonen et al., 2000). The reliability of working within population isolates in 
epidemiological research is well supported, with linear relationships increasing with 
genetic homogeneity (Biino et al., 2013; Bulayeva, 2006; Crawford, 2000; Kristiansson et 
al., 2008). Testing nutritional environmental hypotheses that underlie chronic disease risk 
within these Mennonite populations provides a unique opportunity to study these complex 
relationships. 
 
Nutrition and Disease 
Nutrition and diet are frontline in the prevention, intervention, and treatment of 
chronic disease and conditions (Jones et al., 2013; Konstantinidou et al., 2014; Ness, 
2004). Some of the earliest recorded work of nutrition curing disease was in 1753 by 
Scottish physician, James Lind (Baron, 2009; Lind, 1772; Willett, 2014). While traditional 
roles of nutrition in disease may bring forth canonical examples of rickets, scurvy or a 
form of anemia the contemporary focus in nutritional epidemiology is on chronic diseases 
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and diseases of Western civilization (Carrera-Batos et al., 2011; Melnik et al., 2011; 
Weisberg et al., 2004; Willett, 2014; Yasmin et al., 2016). Early epidemiological work 
demonstrates the direct implication of a nutritional component in disease etiology and 
individual genetic health (Alam et al., 2016; Mead, 2007; Fenech et al., 2011; Lind, 1772; 
Bartholomew, 2002). Nutrients and their receptors interact with genes coding for 
hormones, particularly adipokines, which are central to chronic disease and aging biology 
(Krawczynska et al., 2014; Nimitphong et al., 2009; Xiong et al., 2014). Vitamin D may 
influence normal levels of adipokines adiponectin and leptin (Bidulescu et al., 2014; 
Ghavamzadeh et al., 2014). Cheng et al. (2010) noted that variation in the amounts of 
adipose tissue reflected also the actions of vitamin D after controlling for physical activity, 
smoking, drinking, sex and age. This nutrition-genetic or nutrigenetic approach provides 
exciting potentials in finally placating some long persisting global health problems (Barish, 
2006; Gillies, 2003; Kaput, 2004).  
In the U.S., nutritional or dietary factors are explicitly modifiable especially within 
the context of nutritional deficiencies. Determining individual nutrition health status 
however is challenging due the complex and diversity of diagnostic methods as well as 
poor standardization of measures (Alberti et al., 2006; Subar et al., 2003; Willett, 2014). 
Chronic and metabolic diseases are often comorbid health outcomes resulting from 
nutritional deficiencies, nutritional access and bodily absorption (Via, 2012). While 
synthetic and fortified foods have been instrumental in the global management of nutrient 
deficiencies and disease they are not sufficient substitutes for quality dietary sources that 
supply adequate energy, protein, essential fats and other food constituents required for 
optimal health (Darnton-Hill et al., 2002; WHO, 2009). Sufficient nutritional intake means 
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satisfying three major areas of nutrient responsibility: 1) consumption of enough energy to 
satisfy the amount of energy spent, 2) maintaining physiological processes during basal 
and resting metabolic states processing, 3) replenishing stores within high energy 
demanding tissues and cells such as adipose, neurological and musculoskeletal (Hall et al., 
2012). These three major areas of nutritional function to ensure a robust life and health 
span.  
Individual dietary intake and food preferences are however results of social 
processes and not explicitly biological (Lind et al., 2016; Mintz and Du Bois, 2002; 
Robinson et al., 2014). Authorities on nutritional knowledge can be found in many fields 
of study from the nutritional or biomedical science as well as social disciplines including 
psychology and anthropology (Ferraro et al., 2016; Melnik et al., 2011). Navigation of 
nutritional knowledge can be challenging considering the variation in nutritional 
information and cohesion of nutritional information. Some insufficiencies of knowledge 
about nutritional strategies in treating chronic disease are attributed to poor 
characterization of subpopulations, lack of comparisons between obese and healthy 
individuals, small samples sizes, as well as social and genetic heterogeneity (Bidulescu et 
al., 2014; Edita et al., 2014; Kim et al., 2013; Kou, 2014). What may be defined as a 
healthy or unhealthy diet is multifactorial, determined by location of food sources, 
lifestyles and beliefs, socioeconomics and biology (Fildes et al., 206; Larson et al., 2009; 
Lind et al., 2016). 
Some nutrients, like vitamin D, have a direct effect on many systems but 
importantly adipose tissue and adipose hormones suggesting a possible nutritional 
approach to disease and MetS (Belenchia et al., 2013; Cai et al., 2015; Cheng et al., 2015; 
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Maggi et al., 2013; Wood, 2008). These associations between vitamin D, adipose and 
adipose hormones remain poorly understood however, largely due to biological and 
environmental confounders (Bidulescu et al., 2014; Edita et al., 2014; Jamal-Allial et al., 
2014; Kou, 2014). 
 
Risk Factors of Metabolic Syndrome 
Chronic disease management of dysfunctional adipose tissue is estimated to cost 
the U.S. upwards of 140 billion dollars annually (Zamosky, 2013). Obesity is the single 
greatest risk factor for MetS, unfortunately however, obesity is diagnosed using the flawed 
body mass index (BMI) method resulting in likely misleading reports (Bennasar-Veny et 
al., 2013; Burkhauser and Cawley, 2008; Pories et al., 2010; Rothman, 2008). Obesity also 
increases risk of other chronic disease including cardiovascular disease and cancer (Belardi 
et al., 2013; Roger et al., 2003). What is certain however is that adipose tissue clearly plays 
a significant role in the mechanisms behind chronic and metabolic disease (Tchkonia et al., 
2010). Epidemiological data suggest that concentrations of vitamin D are inversely 
correlated with obesity parameters including BMI, waist circumference, fat mass or 
percent body fat while have a positive association with increase insulin sensitivity 
(Belenchia et al., 2013; Koszowska et al., 2014). 
Metabolic syndrome (MetS) is a constellation of chronic conditions such as 
hypertension, high levels of cholesterol, cardiovascular disease, and obesity. Obesity 
replaced undernutrition and infectious disease as leading contributor to ill health at the turn 
of the last century (Kopelman, 2000).  Flegal et al. (2016) found obesity, the single greatest 
risk factor for MetS.  Obesity is clinically defined as the pathological accumulation of fat 
(adipose) tissue. Obesity levels correlate with cancer rates.  The prevalence for obesity is 
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35 to 40% in the USA (Flegal et al., 2016).  Rates of obesity have doubled between 1980 
and 2014 (Calle et al., 2003; Belardi et al., 2013; WHO, 2014; WHO, 2015). Chronic 
disease management of the health impacts of obesity is estimated to cost the U.S. upwards 
of 140 billion dollars annually (Zamosky, 2013).  Surgery is how some individuals adjust 
to obesity but it is costly and not without risk. Thus, in 2016 there are no successful long-
term treatment options for obesity (Tam et al., 2011). MetS is alarmingly prevalent in the 
general population carrying with it significant morbidity, representing an orchestration of 
advanced aging which facilitates multi-organ disease and all-cause mortality (Fadini et al., 
2011). A considerable degree of ambiguity surrounding MetS lies in the various sex-
specific ways it may present itself (see table 1).  
 




HDL Cholesterol  
(<40 mg/dL males; <50 mg/dL 
females) 
Triglycerides ≥150 mg/dL 
Waist Circumference ≥102 cm males; ≥88 cm females 
Fasting Glucose ≥100 mg/dL 
Blood Pressure ≥85 mmHg diastolic; ≥130 
mmHg systolic 
 
Table 1. The constellation of sex-specific phenotypes indicative of MetS. Greater 
physician consideration of sex-specific differences in diagnostic cutoffs is needed (Jin and 
Benyshek, 2013 pg.97). 
 
MetS proves to be an increasing problem of global proportions (Grundy, 2008). 
MetS and its associated diseases or conditions result from interactions between genetics 
and environment (Corella and Ordovas, 2004; Go et al., 2005; Ordovas, 2008; Xia et al., 
2016). Prior to data collection there was an estimated 20% prevalence of MetS among the 
greater U.S. populace with variations in results depending on nationality, age, 
socioeconomic status, and other predictor variables (Park et al., 2003). Comparative 
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follow-ups find an unyielding increase of MetS within U.S. citizens and stress its 
seriousness as the leading global public health concern (Mozumdar and Liguori, 2011). 
Beltrán-Sánchez and colleagues emphasize the increasing prevalence of MetS and the 
greatest risk factors; highlight the urgency in addressing MetS as a healthcare priority 
(2013). The World Health Organization (WHO) asserts that research in MetS should focus 
on developing and evaluating population-based strategies (Simmons et al., 2009). In order 
to do so, epidemiological studies of nutrition and chronic disease must take note of the 
complex gene-environment interactions experienced in the biocultural environment of 
humans.  
 
Human Variation in Metabolic Disease Risk  
In a large genome-wide analysis, Randall and colleagues (2013) demonstrate the 
genomic determinants of anthropometric traits are likely sex-specific. While adipose genes 
are clearly implicated in many metabolic pathways, the ultimate expression of the adipose 
phenotype varies dramatically by age, sex, nationality, social status, environmental 
endocrine blockers and decreased nutrient content of foods (Grün and Blumberg, 2009; 
Karastergiou et al., 2012; Lee et al., 2007; Schug et al., 2011; Wells, 2007; Wells, 2012).  
Individual differences and inter-personal variation in leptin and adiponectin 
secreted by adipose is determined by biological sex and age (Guerra et al., 2008; 
Kristensen et al., 2000; Lönnqvist et al., 1997; Peake et al., 2005; Wildman et al., 2013). 
Consuming alcohol also impacts circulating adiponectin and leptin concentrations (Makita 
et al., 2013; Otaka et al., 2007). Dimorphic and ethnic differences exist in vitamin D levels 
with women being more likely to be deficient or in states of hypovitaminosis (Bidulescu et 
al., 2014; Smith, 2010; Zadshir et al., 2005). There are sex-specific variations in vitamin D 
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specific to age and developmental period (Dam et al., 2009; Jungert and Neuhäuser-
Berthold, 2015). In general, young people have higher levels of vitamin D than older 
people and males have higher levels than females. The strong sex and age specific factors 
must be considered when designing interventional or therapy responses (Nesby-O’Dell et 
al., 2002). While alcohol consumption and smoking tobacco also effect vitamin D levels 
the strength of these effects are also sex-specific (Brot et al., 1999; Lee, 2012). 
Yannakoulia et al. (2003) colleagues report sex-specific results in relation to body mass, 
adipokine levels and nutrient intake. 
Provided the extensive sex differences in chronic health outcomes, there is a clear 
need for integrated research that focuses on distinguishing the underlying biological and 
social determinants of chronic disease (Goldman et al., 2004). Reliable analyses therefore 
require strict research protocol, multi-method sampling, and ideal populations with social 
and genetic homogeneity (Bansal et al., 2007; Palmer et al., 2011; Polasek, 2009). These 
caveats make studying the multifactorial etiologies of MetS in population isolates ideal 
(Bellia et al., 2009; Benton et al., 2015; Biino et al., 2015; Kolčić et al., 2006; Missoni, 
2009). This thesis examines data collected from a semi-isolate population in the form of 
anthropometric body measures, blood lipid levels, adipokines and nutritional intake values.  
 
Biological Anthropology and Biological Aging 
Few anthropologists, and specifically biological anthropologists, have focused on 
the socio-demographic and developmental biology associated with human aging (Ice, 
2005). Biological anthropology investigations of aging, reproductive ecology and chronic 
disease have been conducted on several Anabaptist Mennonite samples from the Midwest 
U.S. (Crawford, 2000; Devor et al., 1985; Duggirala et al., 2002; Everson et al., 1995; 
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Stevenon et al., 1990; Stevenson et al., 1994; Stevenson et al., 2004). Within one 
Mennonite community, the three leading causes of death were found to be analogous to the 
greater U.S. population; cardiovascular disease, cancer and stroke (Melton, 2006). 
Biological anthropological responses to aging and the associated developmental and 
physiological changes focus on how these processes occur within the context of individual 
variation and various social and biological environments (Crews, 2005). Efforts are spent 
to understand the multiple coordinated systems permitting individual maintenance of 
homeostasis across many environments and stressors during critical developmental and 
reproductive periods. Within context of adipose tissue, central in chronic and metabolic 
disease, its function changes dramatically throughout life (Tchkonia et al., 2010). The 
observed increase in the expression of adipose with age is a product of extensive increases 
or decreases in select hormonal function and production (Michalakis et al., 2013). The 
endocrinology of aging seeks to understand how these hormonal changes accelerate or 
slow the aging process in response to environment (Michael, 2010). A better understanding 
of the dynamics between adipose tissue and the nature of the nutritional environment may 
enhance studies of human variation in chronic disease. 
Chapter 2 covers vitamin D and its synthesis, variation, clinical levels and role in 
the production of adipose. Chapter 3 discusses adipose tissue physiology, its functions as a 
hormone organ and how the body makes new adipose. Chapter 4 talks about adipokines 
adiponectin and leptin, their principle functions as environmental signals and how they can 
be used to address MetS and chronic disease. Chapter 5 focuses on the methods, research 
design of the study as well as a brief ethnohistorical survey of the Anabaptist Mennonite. 





Highlighted in this chapter and several others are the interactions between vitamin 
D and key biomarkers of chronic disease and individual health. Vitamin D is two things as 
once; a nutrient that has been essential to life for hundreds of millions of years as well as a 
steroid-hormone (Holic, 2003b). It is unique in being the only nutrient that is 
independently made by the body using light as well as obtained from animal and plant food 
sources. A majority of vitamin D’s potential in being used as a biomedical target lies in the 
combined efforts of vitamin D and its nuclear receptor (DeLuca, 2004). Once vitamin D is 
consumed and bound to its receptor, this vitamin D-receptor complex is able to directly 
modify genetic activity. Either through binding to additional transcription factors, 
coactivators, or corepressors, vitamin D regulates the expression of over 1,000 genes 
(Carlberg, 2014). Established properties of vitamin D now include roles in the immune 
function, regulation of cellular division and modifying neurohormones (DeLuca, 2004; 
Bikle, 2010). 
 
Evolution of Vitamin D 
Vitamin D is one of the oldest hormones that have been made in the earliest life 
forms for over 750 million years (Holick, 2003b). Vitamin D has been central in the 
evolution of many animals long before humans, primates or mammals (Holick, 2003a). 
The human evolutionary diet, or publicly perceived natural diet, in most human 
populations contains little vitamin D (Naeem, 2010). A co-evolutionary model of vitamin 
D may exist given the biocultural determinants in variation and function. In the presence of 
specific cultural practices as agriculture, modifying modes of nutritional production, and 
clothing in expression or ritual, determine how much vitamin D is getting into the system. 
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It has been hypothesized and criticized that vitamin D may have co-evolved under 
selective cultural practices resulting in lactose tolerance (DeLuca, 2008; Flatz and 
Rotthauwe, 1973). Being able to tolerate greater dairy intake may be advantageous in 
environments with poor solar or nutritional vitamin D supply. Such environmental settings 
include high altitudes, high latitudes, or ecological contexts poor vitamin D production or 
sources. While sufficient vitamin D cannot be produced at higher latitudes, this would not 
have been a challenge for pre-Neolithic European hunter-gatherers, with a robust marine 
diet, while agriculturalists may have suffered (Gerbault et al., 2011; Richards et al., 2003). 
The evolutionary gambit of vitamin D in humans remains understudied and unclear at best. 
 
Vitamin D Synthesis and Production 
Vitamin D is the only nutrient that is made by the body and obtained through food. 
The evolutionary diet, or publicly perceived natural diet, of humans contains little vitamin 
D (Naeem, 2010). Some food sources of vitamin D include egg yolk, fatty fish, and 
fortified products (Heldenberg et al., 1992; Ovesen et al., 2003). While plants are also able 
to produce a form of vitamin D (D2), it does not satisfy the same optima in human health 
and does not achieve the same health benefits as D3 which is produced by animals (Armas 
et al., 2004; Houghton and Vieth, 2006). In its traditionally known roles as a regulator in 
calcium and phosphorus absorption and homeostasis, vitamin D is a central controller in 
making new bone and maintaining bone health. Once obtained, vitamin D must pass 
through several organs before activation and requires a lipid rich environment when 
obtained through diet. Vitamin D has a high bonding affinity with fat molecules called 
chylomicrons and other classes of lipid-proteins (Brannon and Fleet, 2011; Haddad et al., 
1993). This is why vitamin D is sometimes described as a lipid soluble micronutrient in 
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nutrition and medicine. For optimal efficacy and benefit the most reliable form of vitamin 
D for humans to obtain is D3 (Trang et al., 1998; Heaney et al., 2010). For every 100 
international units (IU) of vitamin D ingested, blood levels D increases by 1 ng/ml (Holick, 
2010). While D3 is more appropriate for human health, additional research is needed to 
examine the metabolics of vitamin D and the effects across age, sex, and nationality 
(Calberg, 2014; Tripkovic et al., 2012). Regardless of how vitamin D is acquired it must 
pass through both the liver and kidney in order to have any biological effect (Christakos et 
al., 2010).  
The body’s conversion of cholesterol into vitamin D from UV light is not a linear 
relationship. It is determined by doses of light, frequency of light and the presence of other 
compounds in the skin (Olds, et al., 2008). This means directly increasing exposure to 
sunlight does not result in a proportional increase in available vitamin D. Excessive 
exposure to UV radiation results in the formation of many cancers, particularly cancer of 
the skin and retina (Grant, 2003; Narayanan et al., 2010). Vitamin D is made in the skin by 
reacting a form of cholesterol with UV radiation while nutritional sources are consumed or 
supplemented (Chen et al., 2007; Holick, 2011). In skin cells, UV-B light (290-320 nm) 
help convert cholesterol to pre-vitamin D, becomes vitamin D and then bind to a 
chylomicron and transported to the liver for its first step in activation (Brannon and Fleet, 
2011). The body’s conversion of cholesterol into vitamin D from light however is not a 
linear relationship. It is determined by doses of light, frequency of light and the presence of 
other compounds in the skin (Olds, et al., 2008). Prepared in the skin, previtamin D3 is 
rapidly converted to vitamin D3 by a temperature dependent process. It undergoes a 
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temperature-dependent thermal isomerization that takes at least 3 days to complete 
(Holick, 1980).    
 
Variation in Vitamin D  
Despite the clear importance in human health, differences in vitamin D levels and 
their impacts are enigmatic (Bidulescu et al., 2014; Kaneko et al., 2015; Tripkovic et al., 
2012). In determining individual vitamin D levels it is important to note geographic 
location as levels respond to the natural UV exposure and seasonal periodicity of the sun 
(Heidari and Mirghassemi, 2012; Kimlin, 2008). While 50 to 90 percent of vitamin D 
requirements are satisfied by sun exposure there still persists an overwhelming presence of 
global deficiency (Heidari and Mirghassemi, 2012; Naeem, 2010; Smith et al., 2010). 
Populations in the greater Pacific Northwest region of the U.S. experience intense 
ecological vitamin D deprivation (Johnson, 2010). Producing vitamin D from sunlight is 
initiated by UV-B rays with a wavelength of 295-315 nanometers (nm), but production 
occurs optimally at 297 nm (Stinson, Bogin and O’Rourke, 2012). 
 Dimorphic and ethnic differences exist in vitamin D levels with women being 
more likely to be deficient or in states of hypovitaminosis (Bidulescu et al., 2014; Smith, 
2010; Zadshir et al., 2005). Sex-specific variations in vitamin D also appear to be 
influenced by age (Dam et al., 2009; Jungert and Neuhäuser-Berthold, 2015). In general, 
young people have higher levels of vitamin D than older people and males have higher 
levels than females and leaner individuals have greater vitamin D levels than heavier 
individuals (Yetley, 2008). The strong sex and age specific factors must be considered 
when designing interventional or therapy responses (Nesby-O’Dell et al., 2002). Prison 
populations also suffer from chronically low levels of vitamin D with severity of 
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incarceration as a dramatic determinant (Nwosu et al., 2014). Alcohol consumption and 
smoking tobacco also effect vitamin D levels and the extent to which is sex-specific (Brot 
et al., 1999; Lee, 2012). 
The observed lifestyles, diets and livelihoods in most Western countries often place 
groups in natural or artificial context that are not sufficient for maintaining a safe vitamin 
D status or its associated benefits. Time of day, season of the year, latitude, aging, lotions 
and sunscreens and melanin concentration can all have a dramatic influence on the 
cutaneous production of vitamin D (Heidari and Mirghassemi, 2012; Holick, 2011; Kimlin, 
2008; Webb and Holick, 1988). Vitamin D production does not occur before 9 AM and 
ceases after 4 PM, even in the summer (Holick, 2011). Exposure to sunlight through glass 
will not produce any vitamin D because glass absorbs UV radiation (Holick, 2011; 
Reichrath and Nürnberg, 2009). Vitamin D concentrations are affected by high fat diets as 
well (Lee, 2012; Park et al., 2015; Pinto and Cooper, 2014).  
 
Vitamin D Physiology and Metabolism 
Vitamin D is critically important for the development, growth, and maintenance of 
a healthy skeleton from birth until death (Gennari, 2001; Weaver, 2007). A central function 
of vitamin D is to maintain calcium and phosphorous levels homeostasis by increasing 
intestinal absorption of both (Bouillon and Suda, 2014; DeLuca, 1980). Vitamin D 
communicates to bone cells to dissolve calcium from their stores when there is inadequate 
calcium to satisfy bodily requirements (Holick, 2003b). Vitamin D’s effects go far beyond 
just bone and nutrition health though.  
Vitamin D it is more accurately classified as an active steroid-hormone or 
prohormone (Cutolo et al., 2014; DeLuca, 2004; Verstuyf et al., 2010; Wang et al., 2005). 
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Steroid hormones exert a wide range of physiological responses, including functions in the 
immune system, protein and carbohydrate metabolism, water and salt balance, 
reproductive system and development of sexual characteristics (Lundqvist, 2014). Vitamin 
D as a steroid-hormone has demonstrated many important pleiotropic effects in the body 
(Pike et al., 2014; van de Peppel and van Leeuwen, 2014; Verstuyf et al., 2010). As a 
steroid-hormone itself vitamin D modifies production and function of other hormones in 
the body including sex hormones and steroids (Lundqvist, 2014).  Regulating many gene 
networks, behavior-mediating hormones and other environmental signals, vitamin D 
appears to have heavy behavioral implications; in form, acquisition and function. 
Vitamin D is transported in the circulatory system and throughout the body using 
vitamin D binding proteins (VDBP) (Christakos et al., 2010; Haddad et al., 1993). Relative 
to albumin, one of the most abundant blood proteins, VDBPs are only slightly smaller 
(Holick, 2010). Once vitamin D is made in the skin or ingested from diet, it is transported 
to the liver and kidney to complete the final activation steps. First, removal of a hydroxyl 
group by enzyme CYP27A1 in the liver and removal of a second hydroxyl by CYP27B1 in 
the kidney produces hormonally active vitamin D (Bochud, 2011; Holick, 2007a). 
Activated vitamin D can also be produced outside of the kidneys and can act locally in the 
tissues which produce it (Dusso and Slatopolsky, 1994). While some of vitamin D’s effects 
can occur in the cellular membrane it predominately acts by binding to the vitamin D 
receptor (VDR) and other receptors inside of the cell (Khanal and Nemere, 2007; Mizwicki 
and Norman, 2009). Vitamin D dissociates from the VDBP, enters the cell and then binds 
to and activates the VDR. The vitamin D-VDR complex enters the nucleus joining with 
retinoid x receptor (RXR), to form vitamin D response elements (VDRE). The VDRE 
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complex binds to select DNA sequences in genes and modulates their genetic expression 
(Carlberg, 2014; Mizwicki and Norman, 2009). 
 
Vitamin D and its Nuclear Receptor  
Vitamin D is pleiotropic in its function. It adjusts and modifies genetic activity and 
many gene networks (Pike et al., 2014; van de Peppel and van Leeuwen, 2014; Verstuyf et 
al., 2010). Vitamin D works in a lock-and-key manner and binds to the vitamin D receptor 
(VDR). This nuclear receptor is found widespread throughout the body. Variation in the 
VDR gene are associated with inflammation and obesity (Al-Daghri et al., 2014). The 
vitamin D-VDR complex then enters the nucleus, sometimes binding with additional 
proteins, influencing genetic activity and regulation (Davis and Milner, 2011; Haussler et 
al., 1998l; Kamen and Tangpricha, 2010; Wood, 2008). Vitamin D is known to regulate 
more than 1,000 different genes (Calberg, 2014; Ramagopalan et al., 2010). Gene networks 
influenced by vitamin D are involved in chronic, inflammatory, immunological and 
metabolic diseases. These nutrigenetic capacities influence and possibly enhance 
individual abilities to manage ones genetic health (Chattopadhyay et al., 2003; Davis and 
Milner, 2011). This means dietary intake of vitamin D may be shaping the expression of 
human genetic traits and ultimately phenotypes (Fenech et al., 2011).  
 
Vitamin D: Deficiency, Insufficiency and Disease 
Malnutrition exist in both excess and deficiency (Westerterp, 2013). Clinical 
practice roughly defines 3 forms of malnutrition: starvation related, acute disease related, 
injury related, and chronic disease related (Mauldin and O’Leary-Kelley, 2015). 
Malnutrition is a common symptom of obesity which results in in deficiencies of critical 
micronutrients connected to MetS, especially vitamin D deficiency (Foss, 2009; Via, 
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2012). Some estimates place the global prevalence of vitamin D deficiency for all adults 
and children between 30 and 50% (Gordon et al., 2004; Holick, 2008; Marwaha et al., 
2005; McGrath et al., 2001; Tangpricha et al., 2002). More than 50% of the greater U.S. 
population is living with chronic vitamin D deficiency as well as populations in Canada, 
Mexico, Europe, Asia, New Zealand and Australia (Holick, 2007a). Other risk factors of 
vitamin D deficiency include premature birth, melanin expression, low sun exposure, 
sedentary behaviors, obesity, malabsorption from diet and old age (Holick, 2007b; Lips et 
al., 2006). The general window of acceptable vitamin D is minimally between 20-29 
ng/mL with levels ≥30 ng/mL being optimal (Sadat-Ali and Allq, 2006). Blood levels of 
~150-200 ng/ml approach toxic levels (Holick, 2011). 
UV exposure is insufficient to produce the required quantities of vitamin D in 
people living at extreme latitudes for much of the year (Gerbault et al., 2011). It is 
expected that dietary sources satisfy bodily demands for vitamin D when light proves 
insufficient due to seasonality, geography, or lifestyle. The greatest source of vitamin D in 
the US is fortified foods, however, consumption of both conventional and fortified vitamin 
D food sources have declined (Del Valle et al., 2011). It is generally observed that men 
have higher vitamin D intake than females (Yetley, 2008).  
Where food and sun fail, supplements most commonly employed in treating 
vitamin D inadequacy (Cianferotti et al., 2012). But, in 2008, Qato et al. estimated the 
prevalence and use of over-the-counter medications and dietary supplements in a sample of 
adults 57-85 yrs (n = 3,005). Findings showed only 4.5% of participants used vitamin D 
supplements (Qato et al., 2008). The U.S. and Canadian populations are largely dependent 
on fortified foods and dietary supplements to meet their vitamin D needs. Fortified milks 
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and cereals are the greatest source of vitamin D in the U.S. and fortified milk and 
margarine in Canada (Calvo et al., 2004). Vitamin D deficiency has been linked to obesity, 
as dysfunctional vitamin D levels are directly associated with many chronic and metabolic 
diseases found in obesity as well (Edita et al., 2014; Foss, 2009; Pereira-Santos et al., 
2015; Vanlint, 2013).  
 
Vitamin D in Adipose Tissue and Adipogenesis  
Central to this thesis are the direct interactions vitamin D has with adipose tissue. 
Through its genetic or steroid-hormone abilities, vitamin D is able to changes the 
expression of fat genes, effect adipose tissue communication and adipose cell health (Mutt 
et al., 2014; Ding et al., 2012; Shi et al., 2001) Inflammation caused by adipose tissue is 
the key component to metabolic and chronic disease which vitamin D may potentially 
mediate (Cheng et al., 2010; Ding et al., 2010; Mutt et al., 2014). Vitamin D is frequently 
observed as a reliable predictor of adipose variation even after considering the effects of 
physical activity, smoking, drinking, sex and age (Cheng et al., 2010; Jamal- Allial et al., 
2014; Snijder et al., 2005). Direct relationships between vitamin D and adipose health are 
also observed in healthy individuals otherwise not considered deficient in vitamin D 
(Cheng et al., 2010). Vitamin D deficiency has since been linked to obesity, possible 
causing extreme adipose phenotypes (Edita et al., 2014; Foss, 2009; Pereira-Santos et al., 
2015). In the context of adipogenesis, vitamin D and its nuclear receptor directly affects 











Humans are born with the greatest volumes of body fat or adipose than other 
mammals, believed to support normal and healthy brain development as well as protect 
against times of low or deficient energy in the environment (Leonard et al., 2003). 
Evolution of the large human brain has critical implications for the nutritional biology of 
our species; brain tissue is very energetically and metabolically expensive (Leonard et al., 
2007). For decades it was believed that body fat was just a passive and inert storage space 
for excess calories. It is now recognized as an active component of the endocrine system, 
releasing hormone signals which regulate energy homeostasis (Kershaw and Flier, 2004). 
Decreased physical activity and greater nutritional consumption results in the pathological 
accumulation of adipose tissue, thus disturbing normal hormone balance and energy 
regulation.  
 
Evolution of Adipose 
 The anatomical complexity of adipose tissue morphology and function is not 
frequently explored from an evolutionary stand point (Ottaviani et al., 2011). Far more 
complex within an inclusive context of all organisms, isolated to mammals, adipose tissue 
serves as a central organ in reproduction, survival and health. While some mammals have 
developed tolerances or adaptations for excessive adipose tissue similar observations in 
humans and other primates are neither simple nor linear (Leonard et al., 2003; Pond, 
2012). Conclusions rest now at the interface between brain and adipose tissue as they 
appear to be evolutionarily connected to each other (Grabowski, 2016; McGill, 2014; 
Navarrete and Isler, 2011). While adipose genes are clearly implicated in many bio-
medically relevant pathways, the ultimate expression of adipose phenotypes varies 
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dramatically by age, sex, nationality, social status, environmental endocrine blockers, 
nutritional deficiencies and poor food diversity (Grün and Blumberg, 2009; Karastergiou et 
al., 2012; Schug et al., 2011; Wells, 2012).  
Hypotheses for the evolution and persistence of obesity include the thrifty gene or 
‘genetic mismatch’ hypothesis stating chronic conditions like obesity and MetS result from 
our hunter-gatherer genetics being at odds with modern nutrition and food production 
(Neel, 1962). Alternatively, the drifty gene hypothesis postulates that after humans 
removed themselves from predation, we unintentionally removed the upper limits of our 
body sizes (Prentice et al., 2005; Speakman, 2008). Both hypotheses are likely acting in 
tandem and not alone. The explanatory mechanisms behind obesity are likely epigenetic, 
where genes and their networks are changed according to environmental signals 
(Chakravarthy and Booth, 2004; Herrera et al., 2011; Youngson and Morris, 2013). The 
entirety of the obesity crisis cannot be explained through genetics alone. Nutritional 
deficiencies such as vitamin D deficiency are identified as causative in obesity and 
metabolic disease (Edita et al., 2014; Foss, 2009; Pereira-Santos et al., 2015). Managing 
adipose tissue and the precarious balance between health and disease is a function of both 
culture and biology. Changes in energy balance, including energy availability, storage and 






Figure 2. The major physiological and metabolic processes adipose tissue is active in. 
These processes are guided by adipose derived hormones known as adipokines, including 
adiponectin and leptin.  
 
Adipose Tissue  
Adipose tissue should be more accurately conceived as a hormone organ rather than 
an inert storage tissue (Adamczak and Więcek, 2013; Scherer, 2006; Siiteri, 1987; Więcek 
et al., 2002). It has been discovered to perform complex functions influencing numerous 
physiological systems, even considered a significant organ in maintaining immunological 
health (Grant and Dixit, 2015; Kershaw and Flier, 2004). Finding the “obese gene” and its 
product, leptin, was one of the first empirical observations of a fat cell derived pleiotropic 
molecule, helping establish an important role for adipose tissue among the other endocrine 
organs (Galic et al., 2010; Gorden and Gavrilova, 2003). Placement of adipose tissue in the 
endocrine system requires reexamining the relationships between adipose and other major 
organ systems (Scherer, 2006). While many clinical and epidemiological studies of adipose 
have focused on the suffering induced by excess adipose, disease may arise with zero body 
fat as well (Handelsman et al., 2013; Herranz et al., 2008; Moitra et al., 1998). Given the 
existing abundance, frequent cosmetic removal and natural plasticity of adipose tissue, it 
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has garnered interest among tissue engineers and stem cell scientists (Cawthorn et al., 
2012; Francis et al., 2010; Zuk et al., 2001; Zuk et al., 2002). A greater understanding of 
adipose variation will be beneficial when reevaluating preexisting knowledges of hormone 
biology and adipose related pathologies.  
The relationships between this endocrine organ and the human environment are 
complex. Adipose tissue exists in different forms in order to meet select environmental and 
bodily demand (Giralt and Villorroya, 2013). White adipose tissue is the form most studies 
for its implications in the pathophysiology of many chronic and lifestyle diseases (Chudek 
et al., 2006; Trayhurn and Wood, 2004). Brown adipose tissue has been identified and is 
distinct from white adipose in anatomical location, morphological structure, function, and 
regulation (Cypess et al., 2009; Park et al., 2014). This form of adipose possesses chemical 
properties distinct from white adipose which make it an exciting target for novel metabolic 
therapies. Brown adipose tissue is both more abundant in females than males and is an 
appealing in chronic and metabolic disease research for its ability to increase energy 
expenditure by transforming chemical energy into heat energy (Cypess et al., 2009; Wu et 
al., 2013). Beige adipose as the third form of adipose tissue is relatively new in discovery 
(Lidell et al., 2013). Both brown and beige adipose tissue can suppress weight gain and 
metabolic disease through the action of their specialized, heat-producing adipocytes 
(Harms and Seale, 2013). Distinction of beige adipose from adipose is its formation within 
white adipose itself, earning the technical nickname of brite (brown-like-in-white) adipose 
(Giralt and Villorroya, 2013; Sanchez-Gurmaches et al., 2016). The variety of forms of 
adipose tissue increases the complexity between environmental stress and ultimately 
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phenotypic expression. Variation in individual adiposity appears to be a function of genetic 
and non-genetic factors (Grundberg et al., 2013).   
 
Adipocytes 
 Adipocytes are fat cells. These cells are the primary constituent within the milieu of 
adipose tissue producing adiponectin and leptin. There are many different kinds of fat cells 
found local to the specific variety of fat tissue in the body (Giralt and Villorroya, 2013). 
Adipose tissue may contain few large adipocytes (hypertrophy) or many small adipocytes 
(hyperplasia) (Arner et al., 2010; Rutkowski et al., 2015). Individual contributions of these 
two responses varies depending upon genetic background, modifying behavior, diet, 
biological factors and adiposity pattern (Berry et al., 2013).  Size of fat cells have shown to 
directly influence the levels of secreted adipokines (Skurk et al., 2007). In case of obesity it 
is the expression of adipose genes responsible for a rapid production of new adipocytes 
(Drolet et al., 2007; Jo et al., 2009; Lönnqvist et al., 1995; Lundgren et al., 2007).  
 
Adipose Tissue Signaling and Biochemistry 
Adipose heath is managed similarly to any other organ which means cellular 
communication to and from adipose is very important. Adipose cells and their signaling 
molecules commonly fulfill endocrine, autocrine, paracrine and juxtacrine roles (Dozio et 
al., 2011; Kim and Moustaid-Moussa, 2000; Sweeney, 2011). The adipose gene leptin 
produces an exemplary adipose signaler or adipokine which takes advantage of both 
endocrine and nervous systems to communicate to the body (Mainardi et al., 2013; Nalini 
et al., 2015; Trayhurn and Wood, 2004). Adipose signals are active in monitoring 
processes and behaviors as nutritional intake, blood glucose regulation, and inflammation. 
Integrating the dynamic functions of adipose tissue is aided by the several different tissue 
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types found within adipose tissue (Coelho et al., 2012; Moschen et al., 2011). Collectively 
adipokines directly and indirectly mediate homeostasis and normal function in all major 
organ systems. 
 
Adipokines: Signaling Molecules from Adipose 
 Adipose secretes many adipokines, notably leptin and adiponectin, and a diverse 
range of other signaling factors. The term 'adipokine' is used to describe a protein that is 
secreted from and synthesized by adipocytes (Trayhurn and Wood, 2004). Interestingly a 
positive correlation has been observed between adipocyte size and secretion of adipokines 
with greater adiponectin and leptin production with increasing cell size (Skurk et al., 
2007). Adipokine proteins are active in lipid metabolism, insulin and vascular hemostasis 
as well as regulation of blood and fluid pressure. Production of these proteins by adipose 
tissue is increased in obesity such that irregular levels of adipokines like adiponectin and 
leptin are characteristic of many chronic diseases (Deng and Schere, 2010; Fontana et al., 
2007; Trayhurn and Wood, 2004). Declared as novel markers in chronic disease research, 
adipokines are critical in the enhancement of MetS diagnostics as well as enriching 
individualized health (Deng and Sherer, 2010; Tilg and Moschen, 2006; Van de Voorde et 
al., 2013). Adipokines are implicated in the pathogenesis of obesity and MetS and 
associated cancers (Booth et al., 2015). Applying understanding of adipokines to chronic 
diseases typically associated with Western Civilization may prove beneficial.  
While maintaining high potential in designing novel therapeutic strategies and 
biomedical interventions, standardizing individual adipokines levels is tricky due to 
multifactorial mediators in genetic expression of these proteins but also in population level 
studies (Lee et al., 2007). Several factors influencing individual levels of these hormones 
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include vitamin D, adiposity, smoking and drinking (Al Mutairi et al., 2008). Additionally, 
individual vitamin D levels may also be effects by adiposity and adipokines (Deng et al., 
2010). Further discussion of adipokines can be found in a separate chapter. Focus has been 
given to adipokines due to their causal links to metabolic diseases such as obesity and 
diabetes (Skurk et al., 2007; Hara et al., 2005; Rasouli and Kern, 2008. A greater 
understanding adipokines and their relationships with adipose and the environment will 
hopefully help in addressing adipose related chronic disease (Alvarez-Llamas et al., 2007; 
Pardo et al., 2012; Young and Morris, 2013). Before adipokines may be used in 
interventional models a greater understanding of their variation and environmental 
interactions is required.  
 
Adipogenesis: Production of the Adipose Phenotype 
Adipogenesis is the development of new fat cells or adipocytes (Namwanje et al., 
2016; Rosen and Spiegelman, 2000). The process is exceptionally complex and not well 
understood in totality (Parks et al., 2014; Sanchez-Gurmaches et al., 2016). Fetal 
development of adipose tissue is controlled by the interactions between adipogenic 
transcription factors, nutrients and adipocytokines (Kiess et al., 2008). Maternal and 
endocrine factors also influence specific changes in angiogenesis, adipogenesis, and 
metabolism. Adipogenesis is believed to begin between the 14th and 16th week of fetal 
development (Han et al., 2011; Poissonnet et al., 1983; Poissonnet et al., 1984). 
Approximately ten percent of adipocytes renewed annually at all adult ages and levels of 
body mass index (Spalding et al., 2008). While existing in three forms, all adipocytes of 
each tissue type are derived from the same starting cell (see figure 2).  The ease of 
modifying adipocytes to make stem cells make them ideal for personalized cell therapies 
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Figure 3. Differentiation of mesenchymal cells into a white, brown, beige or brite 
adipocyte or muscle cell. Brown adipose tissue is more closely related to muscle than other 
adipose type since muscle cells and brown adipocytes come from the same stem cell (Park 
et al., 2014 pg. 37, reproduced with permission). 
 
Abnormal gene expression resulting in an abundance of adipose tissue is in part due 
to environment like diet and behavior but also dysfunctional transcription factors. 
Transcription factors work by controlling gene expression. Important adipose transcription 
factors include CCAAT/enhancer binding protein (C/EBP), peroxisome proliferator-
activated receptor (PPAR) and the vitamin D receptor (VDR) (Fu et al., 2005; Ji et al., 
2015; Lefterova et al., 2008; Ricciardi et al., 2014; Zhao et al., 2015). Natural variation in 
some transcription factors can be effected by age. The increased production of anti-
adipogenic C/EBP is possibly due to cellular stress seen with aging (Kirkland et al., 2002; 
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Tchkonia et al., 2007). Transcription factors C/EBP and PPAR are known to act together in 
adipogenesis (Rosen et al., 2002; Rosen et al., 2005; Wu et al., 1999). The expression of 
both PPAR and C/EBP may be regulated by nutrients and hormones (Chapin et al., 1994; 
Jump and Clarke, 1999; Roesler, 2001; Vidal-Puig et al., 1996). All three transcription 
factors however, C/EBP, PPAR and VDR, regulate other physiologies beyond adipose 
tissue (Dhawan et al., 2005; Sertznig et al., 2009a; Sertznig et al., 2009b; Song et al., 
2006). These three proteins, along with the appropriate ligands or activators may be 
instrumental in addressing chronic and metabolic disease (Al-Daghri et al., 2014; Olofsson 
et al., 2008; Robitaille et al., 2004; Tanaka et al., 2003; Wong et al., 2009). For instance, 
C/EBPs work together with VDR to regulate an enzyme central to vitamin D metabolism 
(Dhawan et al., 2005). PPAR-alpha is one form PPAR which serves as an important 
environmental communicator for metabolic adaptations (Contreras et al., 2013). The 
functional processes shared between vitamin D and adipogenesis may be connected and 
responsible for both disease and nutritional epidemics.   
 
PPAR α (alpha)  
 β/δ (beta/delta)  
 γ (gamma) γ1 (gamma 1) 
  γ2 (gamma 2) 
  γ3 (gamma 3) 
C/EBP  α (alpha)  
 β/δ (beta/delta)  
 γ (gamma)  
 ε (epsilon)  
 ζ (zeta)  
 
Table 2. The major adipogenic transcription factors, peroxisome proliferator-activated 
receptor (PPAR) and CCAAT-enhancer binding protein (C/EBP), and their isoforms. 






Vitamin D in Adipogenesis 
  Nutrients interact directly with subcutaneous and visceral adipose tissue in the body 
by differentiating gene expression patterns during periods of fasting and eating, thereby 
changing the response of adipose tissue to environmental signals (Einstein et al., 2005). It 
has been empirically demonstrated that nutritional manipulations can also greatly alter 
adipose tissue phenotypes (Choi et al., 2016a; Choi et al., 2016b; Ferguson et al., 2016; 
Kao et al., 2016; Li et al., 2016; Poulos et al., 2010). A select form of micronutrients 
known as lipophilic nutrients require lipid rich environments in activation and biological 
function. These nutrients are strong modulators of adipose physiology and biochemistry 
(Landrier et al., 2012). Since vitamin D is fat soluble after ingestion or production from 
light it get incorporated and absorbed into body fat. Vitamin D and its nuclear receptor 
have the capacity to directly alter the expression of adipose transcription factors and 
adipokines (Blumberg et al., 2006; Ding et al., 2012; Gysemans et al., 2005; Ishida et al., 
1988; Jamal-Allial et al., 2014; Ji et al., 2015; Kong et al., 2013; Mutt et al., 2014; 
Ricciardi et al., 2014; Stokić et al., 2015; Wood, 2008). Other lipophilic nutrients are also 
able to interfere with the genetic production of adipose (Jamal-Allial et al., 2014; Ji et al., 
2015; Schwarz et al., 1997; Sun and Zemel, 2008). These nutrigenetic mechanisms that 
allow components of food to modify disease risk at a genomic level provide a profound 






Figure 4. The role of vitamin D in the genetic expression of the adipose phenotype (Wood, 
2008 pg. 41, reproduced with permission).  
 
Obesity 
Obesity is a multifactorial chronic disease resulting from complications in energy 
use created by genetic and environmental factors (Koszowska et al., 2014). In 2010 
overweight and obesity were responsible for over 3.4 million deaths worldwide (Ng et al., 
2014). Apart from bariatric surgery, which is costly and not without risk, there are 
currently no successful long-term treatment options for obesity (Tam et al., 2011). Chronic 
disease management of dysfunctional adipose tissue is estimated to cost the U.S. upwards 
of 140 billion dollars annually (Zamosky, 2013). Clinical obesity and surgical bariatric 
procedures also drive reproductively significant epigenetic variation in men (Donkin et al., 
2016). In spite of its several limitations, body mass index (BMI), a measure of individual 
adiposity or body fat, is the most widely used and accepted means for classifying 
overweight and obesity status (Bennasar-Veny et al., 2013; Freedman and Sherry, 2009; 
Oud, 2013; Wright et al., 2015).  
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While obesity is clinically defined as the pathological accumulation of adipose 
tissue, individuals vary significantly in body fat patterning. By the turn of the century, 
obesity replaced undernutrition and infectious diseases as leading contributor to ill health 
(Kopelman, 2000). Within U.S. populations, an association exists between obesity status 
and cancer mortalities, with rates of obesity doubling since 1980 (Calle et al., 2003; 
Belardi et al., 2013; WHO, 2014). This June, Flegal and colleagues (2016) found obesity, 
the single greatest risk factor for MetS, to be over 35% 40% in U.S. males and females 
respectively (2016). Despite community, political and medical interventions and research, 
chronic and metabolic disease prevalence soars.  
Adiposity patterns may determine which comorbidities one experiences from 
excess adipose including cardiovascular disease and MetS (Bennasar-Veny et al., 2013). 
MetS is characterized by the simultaneous presence of multiple chronic and age related 
conditions with obesity as the leading risk factor (Rogers et al., 2003; Scaglione et al., 
2010). Methods attentive to cohort variation in obesity prevalence and age variation in 
obesity's effect on mortality risk suggest that obesity significantly shapes US mortality 
levels, placing it at the forefront of concern for public health action (Masters et al., 2013). 
Based on comparable risk assessment methods, poor health behavior such as lifestyle-
related risk factors are the foremost causes of death and disability in the United States and 
in the world (Go et al., 2014). 
 
 Vitamin D, Obesity and MetS 
Vitamin D deficiency and obesity are both major public health problems 
worldwide, and there is mounting evidence and data that they are connected (Earthman et 
al., 2012). Global obesity has more than doubled since 1980, with more than 600 million 
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adults and 42 million children under the age of 5 obese (WHO, 2014). The US and global 
levels of vitamin D have been declining and obesity rates continuously escalating (Del 
Valle et al., 2011; WHO, 2014). Obesity-associated vitamin D insufficiency is likely due to 
the decreased bioavailability of vitamin D3 from cutaneous and dietary sources because of 
its deposition in body fat compartments (Worstman et al., 2000). Hypotheses of vitamin D 
deficiency have suggested the rates of vitamin D deficiency that are observed in obese 
patients is also a question of sequestration in adipose tissue due and a dilution of 
concentrations by mass (Drincic et al., 2012).  
The shared pathways of vitamin D deficiency and dysfunctional adipose tissue lead 
to the development of many cardiometabolic risks chronic diseases. Edita and colleagues 
(2014) suggest a negative correlation between vitamin D levels and leptin while finding an 
intensive positive correlation between adiponectin and vitamin D. Some studies show an 
inverse association between vitamin D levels and insulin resistance and diabetes while 
improving vitamin D status shows a positive correlation with insulin sensitivity (Ford et 
al., 2005; Scragg et al., 2004). Vitamin D deficiencies have also been shown to reduce 
insulin secretion in a population of East London Asians with 95% of at-risk persons were 
vitamin D deficient (Boucher et al., 1995). The gene considered to be central in developing 
new fat cells (PPARδ) is directly targets and influenced by vitamin D, potentially swaying 
the associations between vitamin D and adipose tissue (Dunlop et al., 2005; Matsuda and 
Kitagishi, 2013; Pike and Meyer, 2010). These data suggest a possible connection between 









The hormones leptin and adiponectin are two examples of adipokines which play 
central roles in managing the energy acquisition and use within the human body. Larger 
implications of adiponectin and leptin include novel roles in modulating lipid phenotypes, 
metabolism and treating chronic disease (Deng and Scherer, 2010; Lago et al., 2009). 
Single nucleotide polymorphisms (SNPs) of the adiponectin or leptin gene may explain 
variation in health and lifespan (Arai et al., 2006; Khabour et al., 2010; Kolovou et al., 
2011). It should be noted that in both men and women, adiponectin and leptin are 
susceptible to environmental silencing in adipose tissue and blood cells depending on 
individual BMI, waist measures and LDL lipids (Houde et al., 2015). These two 
adipokines will be the focus of this chapter. 
Adiponectin and leptin are present at significant concentrations in developing 
tissues during embryogenesis and fetal development (Kiess et al., 2008). Adiponectin and 
leptin are both made within fat cells (Cammisotto et al., 2006; Chandran et al., 2003; Koh 
et al., 2007). The genes for adiponectin and leptin can sometimes be turned off by 
environmental signals (Fasshauer et al., 2002; Stöger, 2006). These hormones help control 
bodily use of energy and body composition (Havel, 2002; Schoppen et al., 2010; Smith et 
al., 2006; Sweeney, 2011). Complications from having high or low levels of these hormone 
often requires clinical intervention and eventually leads to chronic and metabolic disease if 
left unaddressed or undiagnosed (Meirer and Gressner, 2004). There is significant variation 
between individuals in these two hormones which is heavily determined by sex (Ahmed et 
al., 1999; Bidulescu et al., 2014; Lee et al., 2007; Ronconi et al., 2009). Adiponectin and 
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  Discovered in 1995, the adipokine adiponectin is directly implicated in many 
chronic and metabolic diseases in both adults and young children (Kardas et al., 2013; 
Trujillo and Scherer, 2005; Wiecek et al., 2007 Yamauchi and Kadowaki, 2013). 
Adiponectin functions as a hormone in bodily energy homeostasis as well as mediates 
inflammation signaling pathways as an anti-inflammatory (Ouchi and Walsh, 2007; 
Shehzad et al., 2012; Sweeney, 2011). Adiponectin’s additional role as an anti-
inflammatory may explain some of its large implications within MetS and other major 
chronic illnesses (Cai et al., 2015; Matsuzawa et al., 2004; Ohashi et al., 2004). Chan and 
colleagues (2012) report finding adiponectin to be a potential therapy in treating the 
neurotoxicity of Alzheimer’s disease. Possessing many active roles, adiponectin has 
become an important part of many metabolic therapies and chronic disease treatments.  
  As adiponectin is most actively produced by adipocytes it quickly enters the blood 
stream and to then onto the local organ and cells of interest. Tissues requiring regular 
adiponectin homeostasis possess several endothelial cells and layer, requiring specialized 
active transport Predicated upon oligomer size adiponectin requires differential trans-
endothelial transport. (Rutkowski et al., 2014). The pathological accumulation of adipose 
tissue characteristic of metabolic phenotypes is directly due growth and development of 
new adipocytes rather than simply the expansion of existing ones (Jo et al., 2009). When 
circulating in the body adiponectin operates as a globular protein, binding to other 
adiponectin hormones forming larger adiponectin molecules. Decreased levels of 
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adipokines like adiponectin may be pathological and can be caused by interactions with 
specific alleles or environment factors like sleep or even a high-fat diet (Hara et al., 2005; 
Nakagawa et al., 2008).  
Many metabolic pathways of adiponectin interact or utilize vitamin D in order to 
change and regulate many physiological processes, complicated by age, sex and individual 
adiposity (Bidulescu et al., 2014; Kardas et al., 2013). A mutual site of interest in 
adiponectin and vitamin D metabolism is the adipocyte. While adiponectin is synthesized 
within adipocytes, vitamin D is stored in them and aids in adipocyte energy homeostasis 
(Ding et al., 2012; Edita et al., 2014; Mutt et al., 2014). Enhancing understanding of 
adipokines and nutritional intake may prove beneficial in designing individualized and 
economically open interventions to MetS using diet and adipokines like adiponectin.   
 
Leptin 
Leptin’s name is derived from the Greek word “leptos” generally meaning thin 
(Kelesidis et al., 2010). With the discovery of leptin and its production by adipose helped 
pioneer the concept that adipose tissue was not just an inert storage organ but rather an 
active component to the endocrine organ system. Leptin is another important adipokine 
made in adipose and other tissues including placenta, ovaries, mammary epithelium, bone 
marrow, and lymphoid tissues (Cammisotto et al., 2006; Margetic et al., 2002). This 
implies leptin’s involvement in other physiological system, including reproductive, 
immunological, and cellular growth (Fantuzzi, 2006; Gat-Yablonski and Phillip, 2008; Hill 
et al., 2008). Leptin is important in maintaining many health systems particularly in 
regulating and maintaining adipose tissue, weight and energy balance (Chehab, 2000; 
Friedman and Halaas, 1998l Mantzoros et al., 2011; Nalini et al., 2015; Frühbeck and 
36 
 
Pentice, 1998). Identified in 1994, leptin was believed to be the treatment to many chronic 
and metabolic diseases; especially obesity (Gautron and Elmquist, 2011). Leptin is capable 
of indicating nutritional and energy deficits as well as predict future feeding and food 
intake (Chin-Chance et al., 2000; Margetic et al., 2002; Vinyard et al., 2012). 
Total leptin in the body includes free floating and protein bound leptin (Brabant et 
al., 2000). The leptin receptor and its concentrations are dependent upon individual sex 
hormones, adiposity, sleep cycle and present levels of leptin (Chan et al., 2002). Unlike the 
manner in which adiponectin moves through body, leptin uses receptor-mediated 
transcytosis (Cammisotto et al., 2010). Unique to the leptin hormone is its ability to also 
function as a neurotransmitter, fulfilling roles in maintaining healthy neural development 
and plasticity (Mainardi et al., 2013; Paz-Filho et al., 2008). Since leptin communicates to 
the body using both nervous and endocrine systems it may be more accurately described as 
a neuro-hormone (Ahima et al., 2000; Wauters et al., 2000). One of the sources of interest 
in leptin is its ability to directly control feeding behavior using neural circuits (Bouret et 
al., 2004; Crespi and Unkefer, 2014). Highlighting its nervous and metabolic roles, leptin 
is responsible in regulating where adipose tissue is stored on the body (Schoppen et al., 
2010; Smith et al., 2006).   
Minocci et al. (2000) find that an individual’s leptin concentrations are heavily 
dependent upon not just amount of adipose but also its distribution on the body. Between 
visceral and subcutaneous adipose, leptin production and secretion appears to be anywhere 
from two to four times greater in subcutaneous adipose in women, both lean and obese 
(Van Harmelen et al., 1998). Exogenous leptin administration in normal weight samples, 
leptin responsive inhibits food intake and reduces the size of body fat (Harris, 2014). When 
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fat mass falls, plasma leptin concentrations fall too, stimulating appetite and suppressing 
energy expenditure until fat mass is restored while an increase in fat mass results in an 
increase in leptin levels, suppressing appetite until weight is lost (Friedman, 2010). Leptin 
is thereby conveying nutritional information to the brain, which in turn regulates most, 
perhaps all, other physiological systems. The homeostatic functions of maintaining energy 
use, acquisition and individual adiposity are central to leptin’s role as a neuro-hormone 
(Blundell et al., 2015; Schoppen et al., 2010; Smith et al., 2006; Wynee et al., 2005). 
Leptin is a powerful environmental signaler provided its importance in navigating 
both nervous and endocrine systems. Leptin is understood to be protective against periods 
of ecological famine and feast by signaling the periods of environmental stress to the body 
(Crespi and Unkefer, 2014; Unger, 2005). This neurohormone enables humans and other 
animals to maintain levels of stored energy under many different environmental 
conditions. Due to its large role as an environmental signaling molecule, leptin is 
susceptible to environmental silencing, meaning the leptin gene may be tuned off or not 
expressed (Stöger, 2006). Leptin’s modulation of eating behavior, satiety and adipose 
tissue are arguably the leading considerations for its novel applications in aging and 







Figure 5. Illustration of the adipose-leptin-neural circuit. The principle effects of 
leptin are on feeding behavior, metabolism and fat mass (adapted from Friedman et al., 
2010 pg. 1103). 
 
Clinical Significance of Adipokines 
Adiponectin dysfunction is a functional means to diagnose chronic illnesses like 
MetS and obesity (Hu et al., 1996; Kohara et al., 2014; Goldstein and Scalia, 2004). For 
this reason, concentrations of adipokines like adiponectin and leptin have been used in 
diagnosing and management of many different forms of metabolic disease in humans 
(Deng and Schere, 2010). Adipokines execute mediating homeostatic functions in 
maintaining adipose tissue health and communication to other tissue systems (Lago et al., 
2007; Tilg and Moschen, 2006; Xu and Vanhoutte, 2012). Adipokines leptin and 
adiponectin have demonstrated novel pharmacological potentials in treating and 
diagnosing chronic disease (Deng and Scherer, 2010; Van de Voorde et al., 2013). In fact, 
collection of biological samples or “biomarkers” along with nutritional information should 





Nutritional and epidemiological investigations must go to great lengths in 
identifying ideal sample populations, gaining access, and establishing well defined 
parameters prior to data collection. While prevalence of vitamin D deficiency in the 
general population is alarmingly high, action is warranted and should be focused upon the 
population level rather the risk group level (Hyppönen and Power, 2007). The Kansas 
Mennonite are socio-culturally distinct in religious practice, migration history and cultural 
origins. Because of this relative isolation working with the Anabaptist communities is an 
opportunity to conduct a comparative and population level study on nutrition and markers 
of disease risk. Details and rationale of data collection methodologies are documented in 
Mosher et al. 2016. The objective of this research was to determine any sex-specific 
relationships between nutritional intake and concentrations of adiponectin and leptin in this 
Mennonite population.  
 
Population and Participants Studied 
The Anabaptist faith goes back to the Protestant Reformation in 1517 started by 
Martin Luther in present-day Wittenberg, Germany (Collinson, 2007; MacCulloch, 2004). 
Around 1525 formal Anabaptist sects were recognized in Germany, Switzerland and the 
Netherlands (Rogers and Rogers, 2000). Under the larger religion of Protestantism, 
Anabaptism divides into three primary denominations: Mennonite, Amish and Hutterite. 
Anabaptist populations have experienced many migratory occasions which have 
contributed to their social and biological isolation (see figure 7) (Crawford et al., 1989; 
McKusick, 1973; Pichler et al., 2010; Puffenberger, 2003). Upon the crumbling of Polish 
royal power in the 17th century, Poland was partitioned among Russia, Prussia and Austria. 
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Because of this, much of the Mennonite population came under Prussian rule. The 
Mennonite way of life and religion that developed under Polish rule was now threatened 
and in danger. This cultural persecution and change in politics paired with the propositions 
of free land provided significant motivation for Mennonite families to move to Russia 
beginning in 1788 (Friesen, 1989). 
The Kansas population in this study has undergone several migrations as a result of 
social and religious persecution, figure 8 illustrates the fusion and splitting along 
congressional lines and the sharing of common migration histories (Crawford, 2000). The 
act of immigrating is an instance of forsaking cultural and linguistic heritage for the 
purpose of adapting to entirely different environments, surroundings and people (Buchheit, 
2009). Moving to locations with differences in climate, food chain, social and economic 
factors can have consequences for individual health and wellbeing (Mosher, 2012). 
Coming into contact with intricate cultural strategies in managing environmental change 
can lead non-assimilation after migrating, instead forming religious, cultural and linguistic 
isolate communities to maintain cultural homogeneity and identity preservation. The 
settling of the Kansas Mennonite in the 19th century, along with other Anabaptist groups, 






Figure 6. Map illustrating several Mennonite migrations across Central and East 
European countries from Germany, city of Danzig, Poland (contemporary Gdańsk), 
Ukraine and Sweden (Crawford, 2000 pg. 39; reproduced with permission).  
 
The Mennonite successfully established autonomous peoplehood characterized by 
nonconformity enforced by the exclusive use of German and spatial isolation (Engbrecht, 
1985). As religious and economic refugees, Mennonite groups emigrated across Europe 
and into parts of the U.S. in 1874, Canada in the 1870’s as well and Mexico in the 1920’s 
(Allen, 1988; Keel, 2012; Rogers and Rogers, 2000; Stevenson and Everson, 2000). 
Immigration to the U.S. in 1874 is a demonstration of efforts to retain ethno-religious 
distinctiveness and rights. The Mennonite sought complete society autonomy in the U.S. 
but instead were offered individual self-sufficiency (Engbrecht, 1985). Upon arrival to the 
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U.S., the Mennonite became two separate groups with one group settling in Lincoln, 
Nebraska and the second near Wichita, Kansas.  
 
 
Figure 7. Map of Kansas, surrounding states and geographic distribution of some 
Mennonite congregations (from Melton, 2010 pg. 270). 
 
While Amish and Hutterite communities have received considerable interest from 
researchers and scholars, Allen and Redekop (1967) were the first to conduct a study that 
focused specifically on non-Amish Mennonite. Collaboration with the Anabaptist 
Mennonite communities of Kansas and parts of the Midwest has been extensive (Crawford, 
2000; Demarchi et al., 2005; Melton, 2012; Stevenson, Everson, and Crawford, 1989). 
While each Anabaptist religion has its own distinct cultural history, the Mennonite have 
settled across the U.S. several times in recent history. In 1858 John Halderman founded the 
Church of God in Christ Mennonite in Ohio (Melton, 2010). This particular group is 
considered a mix of Pennsylvanian Dutch, Germans and Mennonite immigrant populations 
from Russia (Crawford, 1989). The Halderman congregation soon split into the Meridian, 
Garden View and Lone Tree of Kansas. The most recent Mennonite immigrants to Kansas 
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are the Old Colony Mennonites in the 1990s to Garden City. This particular group traces 
its history to a group of Mennonite who originally immigrated to West Canada, then 
Cuauhtémoc, Chihuahua Mexico in the 1920’s and finally to Kansas (Allen, 1988; Allen 
and Redekop, 1967). In this thesis participants come from several Kansas Mennonite 




Figure 8. Ethnohistorical dendrogram of the Anabaptist Mennonite congregations (Martin 
et al., 1996 pg. 49, reproduced with permission). 
 
 Previous work has established the relatedness between some Anabaptist Mennonite 
congregations and families of the Midwest (Demarchi et al., 2005; Melton, 2010; Martin et 
al., 1996). Within the last 250 years the Mennonite of the Midwest have lived in three 
different locations and with distinct demographic contexts in each place (Rogers and 
Rogers, 2000; Stevenson and Everson, 2000; Stevenson, Everson and Grimes, 2004). The 
Kansas Mennonite practice largely traditional agricultural lifestyles, do not smoke or drink, 
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maintained extensive genealogical records and may share similar nutrition histories among 
them (Crawford, 2000; Rogers and Rogers, 2000). These cultural features of the 
Mennonite provide more reliable context in which to ask questions about nutrition and 
human health. Exclusion of smoking and drinking behaviors enhances data interpretations 
as these effect hormone and nutrient levels. Analogues to the greater U.S., the greatest 
cause of mortality among some Mennonite communities is chronic disease including heart 
disease, cancer and stroke (Melton, 2006). For these reasons the Mennonite of Kansas 
serve as an ideal population for studying the relationships between nutrition and 
phenotypes associated with disease.  
This thesis uses previously collected data from the Kansas Nutrition Project (KNP) 
designed by Dr. M.J. Mosher and Dr. Michael Crawford at the University Kansas. The 
KNP sought to provide nutritional knowledge and context of Mennonite farming 
communities, examining relationships between nutrition, genes and chronic health and 
check for nutrition and health patterns within families. Researchers met with each 
congregation in their respective churches and explained the nature of the work. Samples of 
volunteers attended clinics that were held the week after community meetings. Particularly, 
data collected and analyzed occurred between 2003 and 2005. Sample collection included 
nutritional data in the form of three nonconsecutive days of food diary entries, fasting 
blood draws for hormone and lipid profiles and standard anthropometric and skinfold 
measures for body composition. Funds for the original project come from the State of 
Kansas Attorney General’s Settlement Fund. This thesis is covered by IRB clearance under 





Diet and Adipokines in Non-Human Studies 
 Adipokine concentrations are used in diagnosing and treating metabolic conditions 
in non-human primates including Rhesus monkeys and Cynomolgus macaques (Bauer et 
al., 2011; Wagner et al., 2006; Hansen, 2001; Hotta et al., 2001). The effects of vitamin D 
on markers of metabolic health are also observed in non-human animals including murine 
and porcine models. Past work has shown a high fat diet resistant lean phenotype in 
vitamin D receptor null mutant mice suggesting a role for vitamin D in energy metabolism 
(Wong et al., 2011). Zeitz et al. (2003) report increased glucose levels in mice with 
functionally inactive vitamin D receptors while comparing diets enriched with calcium, 
phosphorus and lactose to both wild-type and mutant mice. Vitamin D deficiency often 
coexists with non-alcoholic fatty liver disease resulting in the dysfunction of this tissue 
central in vitamin D metabolism and activation (Eliades and Spyrou, 2015). Mice fed diets 
high in both vitamin D and calcium demonstrate activation of calcium mediate apoptotic 
protease pathways within mature adipocytes (Sergeev and Song, 2014). Vitamin D 
receptor null mice display a reduction in adipose mass, reduced plasma triglycerides and 
reduced cholesterol under normal calcemic conditions relative to wild-type counterparts 
(vinh quốc Lương and Hoàng Nguyễn, 2013). It has been shown that mice treated with 
vitamin D have increased adiponectin concentrations and mice without the vitamin D 
receptor have reduced leptin levels (Narvaez et al., 2009; Suarez-Martinez et al., 2014). 
Vitamin D is also found to increase leptin expression in mice (Kong et al., 2013). 
Adipokines like adiponectin appear to be intimately linked to obesity and 
inflammation in pigs and humans (Eliades and Spyrou, 2015). Ontogenetically, the 
expression of adiponectin and leptin increase over time in pigs (Ramsay and Caperna, 
2009). Comparative dietary studies suggest nutritional regulation of adipokines 
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adiponectin and leptin in mini-pigs (Yang et al., 2013). Vitamin D deficiency in groups of 
pigs results significant changes in key metabolic and cardiac health markers including 
decreases in adiponectin within epicardial adipose (Gupta et al., 2012). Leptin 
concentrations are increased by high-energy diets as well as post-transcriptional 
mechanisms in pigs (Chen et al., 2006). Observed effects in non-human animals may be 
complicated by the recruitment of many molecular cascades within many tissue types 
(Suarez-Matinez et al., 2014). 
 
Diet and Adipokines in Humans  
Nutrients and their receptors interact with genes coding for hormones, particularly 
adipokines, which are central to chronic disease and aging biology (Krawczynska et al., 
2014; Nimitphong et al., 2009; Xiong et al., 2014). Vitamin D may directly or indirectly 
influence normal levels of adipokines adiponectin and leptin (Bidulescu et al., 2014; 
Ghavamzadeh et al., 2014; Kong et al., 2013; Maetani et al., 2009; Menendez et al., 2001; 
Vaidya et al., 2012). While vitamin D has been shown to regulate the expression of some 
adipokines, these relationships are sensitive to age, sex, smoking, drinking, nationality and 
BMI (Bidulescu et al., 2014; Lee et al., 2007; Menendez et al., 2001; Sun and Zemel, 
2008). Pischon et al. (2005) report modest alcohol consumption increasing adiponectin 
concentrations while a diet high in carbohydrates reduces concentrations, further 
supporting diet-adipokine interactions. Bidulescu et al. (2014) assert that associations 
between vitamin D and adiponectin to be strongest in females, any associations are 
dependent upon age, BMI and ancestry (Bidulescu et al., 2014). Cheng and colleagues 
(2015) find that variations in vitamin D enzyme genes are significant in determine ratios of 
adiponectin and leptin in a representative male Taiwanese sample. The effects of vitamin D 
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on adipokine phenotype is observed in both health and sick populations (Kim et al., 2013; 
Vilarrasa et al., 2010). The associations between vitamin D and adipokines have been 
examined in relation to cancer, bone protection in diabetic patients and MetS research 
(Cheng et al., 2015; Gannagé-Yared et al., 2009; Kasiappan et al., 2014; Lara-Castro et al., 
2007; Maggi et al., 2013). Correlations between vitamin D and adipokines however may 
not be significant in those with additional endocrine complications such as thyroid 
disorders (de Luis et al., 2012). Vitamin D’s influence on adipokine concentrations is also 
partially determined by intake of other nutrients such as calcium, vitamin A or vitamin E 
(Mendez et al., 2001; Tabesh et al., 2012; Xiong et al., 2014). Jamal-Allial et al. (2014) 
noted that levels of vitamin D predict adiposity phenotype. Effects of vitamin D on 
adipokine levels are observed in healthy and sick populations (Kim et al., 2013; Vilarrasa 
et al., 2010). 
Some investigations are criticized for producing conflicting results and suffering 
from poor research design.  A critical look at Bidulescu’s experimental design reveals 
insufficient understanding of subpopulation characteristics, suboptimal sampling methods, 
small sample sizes and use of highly heterogeneous populations (Kuo, 2014; Lee et al., 
2007). The Kansas Mennonite provide a unique opportunity to examine such gene-
environment hypotheses with insulation resulting from the shared migratory histories, 
agricultural traditions, cultural and religious isolation of the Mennonite within greater 
America. Investigations in this study include the relationships of vitamin D intake with 
adipose and adipokine phenotypes. Adiponectin and leptin both possess high potential for 
treating and preventing chronic and metabolic disease (Deng and Scherer, 2010; Mattu and 
Randeva, 2013; Patel et al., 2008). Vitamin D is an active deciding factor in adipogenic 
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processes, interacting with circulating levels of adipokines and modifying genetic 
production of adiponectin and leptin (Bidulescu et al., 2014; Lee et al., 2007; Menendez et 
al., 2001; Sun and Zemel, 2008). I predict any correlations to operate within a dimorphic 
model with sex-specific associations between vitamin D and adipokine phenotype. 
 
Nutritional Data 
 Nutrition is determined by many factors including evolution, food allergies and 
local ecosystems, individual preferences and bodily growth and development 
(Amarasekera et al., 2013; Oshaug, 2006; Patel et al., 2013). Diet, the manifestation of 
individual food preferences, is partially determined socially and psychologically 
(Johansson et al., 1999; Shepard, 1999). Many social variables greatly influence nutrition, 
individual diet as well as effecting knowledge and decision making processes about food. 
Food choices must be made multiple times a day and may exist between options that are 
realistic, preferred, sustainable and economic and geographically accessible. 
Socioeconomic standing, political ecology and local production-sustainability models are 
all major deciding factors in shaping and determining a person’s diet (Contento, 2007; 
Patrick and Nicklas, 2005). In nutritional studies there are three methods that can be used 
to determine an individual nutritional status; questionnaires, diet recalls and biomarkers 
(Ocké and Kaas, 1997; Willett, 2014). KNP participants were asked to keep food diaries, 
the gold standard and ideal method at the time for collecting individual nutritional habits 
and dietary patterns. Nutritional data were later entered into NutriBase™ processing 
software to analyze macro and micronutrient values of foods consumed. This permitted the 
construction of individual nutritional intake profiles of each participating Mennonite, 
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recoding their macro and micronutrient intake from their own described foods, recipes and 
conception of nutritional environments.  
 















                         




Figure 9. Comparison of the three ways individual nutrition status can be measured in 
epidemiological investigation: (A) questionnaires, (B) dietary recalls and (C) molecular 
techniques, where p is the validity coefficient, r is sample correlation and T is true intake 
value. When statistically compared, differences between these methods are negligible (see 
Appendix A) (adapted from Ocké and Kaas, 1997 pg. 1241 and Willett, 2014 pg. 123). 
 
In most epidemiological applications, long-term diet is the most rationale level of 
exposure, with studies focusing on physiological intermediates or changes interested in 
smaller time windows (Willett, 2014). Measuring and quantifying individual nutrition and 
dietary intake with high precision is challenging however (see figure 10) (Jl, 1993; Kipnis, 
2002). In a contrast, a smoker can tell you how many and how frequently they smoke 
within an accurate average whereas asking most individuals what, how much and how 










forces influencing variation in diet is essential in choosing an appropriate method to assess 
diet and to interpret data collected using various methods (Willett, 2014).   
 
 
Figure 10. The process of determining the strength, weaknesses, common sources of error 
and objective and subjective limitations in dietary assessment. Picking the ideal method to 
measure or determine individual diet pattern requires navigating the different stages and 
levels people may construct or perceive their nutrition environment (adapted from 
MacIntyre, 2009 pg. 8). 
 
Serological Samples 
Central to the KNP objectives, nutritional and genetic interactions can be studied if 
biological samples are obtained (Bingham, 2002). Designed by researchers at the 
Laboratory of Biological Anthropology at the University of Kansas, the KNP included 
fasting blood draws for serological data including circulating blood lipid levels, serum 
hormone concentrations and extraction of DNA. Blood samples were collected by 
venipuncture from participants of each congregation. These samples were centrifuged in 
order to isolate important blood components such as plasma which was frozen on site 
(Demarchi, 2005). Centrifugation also provided DNA extraction from the buffy coat, the 
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layer of separated blood with the greatest number of leukocytes and platelets, using a 
Quick Gene Kit (Analytical Genetic Testing Center, Denver, CO). Fasting blood draws 
also provided accurate levels of adiponectin, leptin and circulating lipids including 
triglycerides, high density and low density cholesterol. LDL cholesterol was calculated 
using Friedewald’s calculation (Friedewald et al., 1972; Mora et al., 2009).  
 
Anthropometrics 
Quantifying adipose tissue with considerable accuracy is not simple (Deurenberg et 
al., 2001). Calculated by taking one’s weight divided by their height squared, variation in 
BMI scores is predicated on whether weight and height measures are self-reported or 
empirically measured such as using a scale (Stommel and Schoenborn, 2009; WHO, 2014). 
BMI limitations are many as it has no means to account for the different forms of adipose 
one has, fails to discriminate between weight from muscle, bone or fat and BMI has little 
to no diagnostic power (Romero-Corral et al., 2008). Despite inherent shortcomings, body 
mass index (BMI) is the most widely used and accepted method in determining individual 
adipose tissue (Bennasar-Veny et al., 2013; Freedman and Sherry, 2009; Oud, 2013; 
Wright et al., 2015). Individuals differ not only in the amount of adipose they store, but 
also in bodily distribution of it (WHO, 2015). The distribution of fat induced by weight 
gain affects the risks associated with obesity and the kinds of diseases that result from it 
(Canoy et al., 2007; Després et al., 1990; WHO, 2015). KNP participants had their BMI’s 
calculated by taking scaled measures of weight and height as well as skinfold taken over 
thin or light clothing around the triceps, subscapular, waist, wrist and hip regions. No thigh 
measures were taken out of deference for the participants. Adipose measures can become 
more accurate in capturing the differences in fat pattern by including measures of skinfolds 
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from specific body regions (Bl, 1990; Moreno, 20002; Wells, 2007). Interestingly it is also 
believed that measures of the leptin hormone directly reflect body mass as well (Brabant et 
al., 2000).  
 
 Statistical Tests 
All statistical analyses were completed using SPSS® version 23. Univariate 
analyses were conducted to assess normality; any non-normally distributed data were 
natural log transformed including nutritional intake values, blood lipids and adipokine 
concentrations. All tests were run sex-stratified and adjusted for age. One-way ANOVA 
tests were performed to determine and statistically significant differences in average 
measures of each variable between males and females. Hypotheses and assumptions were 
checked using tests of coorelation and constructing multiple linear regression models with 
a selected significance of p < 0.05. These models evaluate the relationships between leptin 
and adiponectin and nutritional, anthropometric and biological variables (blood lipids).  
 
 Limitations 
  Limitations to the study include exclusions of important metabolic information 
such as blood glucose and insulin and narratives of food preparation practices. Future 
research could include collection of these biomarkers ethnographic surveys on nutritional 
knowledge, attitudes and practices. Epigenetic information relevant to adiponectin, leptin 
or the vitamin D receptor would provide valuable insight to gene-environment and gene-











Characterization of sample 
 
N=160 (84 females; 76 males) 
Population age range: 20 to 90  
Average age for females: 57 (± 17.13) 
Average age for males: 52 (± 16.09) 
 
Anthropometrics 
 Anthropometric measures include weight, height and BMI score as well as body 
region skin folds for the measure of individual adiposity and dimorphic patterns in adipose 
phenotype. In males, height and weight were 178.3 cm (± 6.4) and 186.3 lbs. (± 31) 
respectively. The average BMI score was 26.5 (± 3.7), average hip measure 106.8 (± 7.5), 
waist measure 97.6 mm (± 8.7) and average wait-to-hip ratio 0.91 (± 0.91). Comparatively, 
the average score for every anthropometric measure was greater in males than females 
except in average triceps measure at 16.6 mm (± 5.8) in males and 26.4 mm ± 6.3 in 
females. In females, height and weight were 164.9 cm (± 7.8) and 151 lbs. (± 25.8) 
respectively. The average BMI score was 25.3 (± 4.3), average hip measure 105.6 (± 9.3), 
waist measure 79.9 mm (± 9.3) and average wait-to-hip ratio 0.7 (± 0.04).  
 
Nutritional Intake 
 All micronutrient intake values were natural log transformed for normality of 
distribution. Individual nutrients selected for analyses were determined by solubility rules 
and isomerization in light. The greatest average nutrient intake was vitamin A at 8.5 IUs (± 
0.6) of vitamin A and the lowest was vitamin E at 1.8 IUs (± 0.7). Average vitamin D 
intake scored at 3.7 IUs (± 1.2), average calcium 6.7 IUs (± 0.4) and average folate at 5.6 
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IUs (± 0.4). In females, the greatest average intake was vitamin A at 8.5 IUs (± 0.6) and 
the lowest average intake score was vitamin E at 1.7 IUs (± 0.7). Average vitamin D intake 
in females was 3.2 IUs (± 1.5), average calcium 6.7 IUs (± 0.4). Overall, males had the 
greatest average intake of every nutrient except for average intake of vitamin A which was 
the same in both sexes however with different standard deviations of ± 0.6 in males and ± 
0.7 in females. 
 
Blood Lipids 
 Blood lipid levels are useful phenotypes in understanding changes and sex-specific 
variation in the nutritional environment and overall bodily health. In males, the average 
levels of HDL cholesterol levels of 42.2 mg/dl (± 10.3), average LDL cholesterol 111.8 
mg/dl (± 29.8), average triglycerides 120.6 mg/dl (± 63.8) and total cholesterol 178.2 
mg/dl (± 34.3). In females, average HDL cholesterol was 56.3 mg/dl (± 15), average LDL 
cholesterol was 110.8 mg/dl (± 34.5), triglycerides 123.1 (± 72.2) and total cholesterol 
191.7 mg/dl (± 38.1). On average, males had lower HDL cholesterol, triglycerides and total 
cholesterol than females but greater average LDL cholesterol.  
 
Adipokines 
 In males, average adiponectin levels were 2.1 ug/ml (± 0.5) and average leptin 
levels were 1.6 (± 0.6). In females, average adiponectin was at 2.5 ng/ml (± 0.5) and 
average leptin levels were 2.6 ng/ml (± 0.6). Both adipokines were found to be in higher 







Table 10. Sex-stratified summary of the calculated averages and standard deviations for 
anthropometrics, nutrient intake, blood lipid and adipokine levels for females (n=84) and 
males (n=76). 
 
Female Average Std. Dev. Anthropometric Male Average Std. Dev. 
164.9 7.8 Height (cm)* 178.3 6.4 
151.1 25.8 Weight (lbs.)* 186.3 31 
105.6 9.3 Hip (mm) 106.8 7.5 
79.9 9.3 Waist (mm)* 97.6 8.7 
16.1 .8 Wrist (mm)* 18.6 0.96 
26.4 6.3 Triceps (mm)* 16.5 5.8 
21.6 7 Subscapular  (mm) 22.5 6.8 
25.3 4.3 BMI* 26.5 3.7 
0.7 0.04 WHR* 0.91 0.03 
     
Female Average Std. Dev. Nutrient (IUs) Male Average Std. Dev. 
3.2 1.5 Vitamin D* 3.7 1.2 
8.5 0.7 Vitamin A 8.5 0.6 
1.7 0.9 Vitamin E 1.8 0.7 
6.3 0.4 Calcium* 6.7 0.4 
5.3 0.4 Folate* 5.6 0.4 
     
Female Average Std. Dev. Lipid (mg/dl) Male Average Std. Dev. 
56.3 15 HDL* 42.2 10.3 
110.8 34.5 LDL 111.8 29.8 
123.1 72.2 Triglycerides 120.6 63.8 
191.7 38.1 Total cholesterol* 178.2 34.3 
     
Female Average Std. Dev. Adipokine Male Average Std. Dev. 
2.5 0.5 Adiponectin (ug/ml)* 2.1 0.5 
2.6 0.6 Leptin (ng/ml)* 1.6 0.6 
*Statistically significant differences between females and males (p<0.05).  
 
The Vitamin D and Adipokine Study 
Using data previously collected for the KNP, I investigated hypotheses about the 
interactions between adipokine phenotypes and nutritional intake in a semi-isolate group of 
Kansas Mennonite. Anthropometric, nutritional and serological variables were highly 
intercoorelated and proved to be significant predictors of both adiponectin and leptin levels 
in males and females. Initial tests of adipokine concentrations against vitamin D intake 
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exclusively were not strong or reliable. Inclusion of anthropometric and biological traits 
increased the strength and clarity of linear relationships between vitamin D and adipokines. 
 
Adiponectin in Women 
Variation in average adiponectin between females was statistically significant (p = 
0.001). The adiponectin model in females shows age, wrist, hip and subscapular measures 
and HDL cholesterol were significant predictors, explaining up to 35.8% of adiponectin 
variation (F = (5, 77) = 8.57) (p < 0.001). In females, the strongest variables determining 
adiponectin levels were HDL cholesterol (β = 0.344, p < 0.001), wrist circumference (β = -
0.309, p = 0.002 and age2 (β = 0.237, p = 0.017) with hip adiposity possibly contributing 
to the observed trend as well (β = 0.218, p = 0.067). 
 













Df1 Df2 Sig F 
Change 
1 0.598 0.358 0.316 0.4473 0.358 8.578 5 77 0.000 
 
Adiponectin in Men 
Variation in average adiponectin between males was statistically significant (p = 
0.001). In males, the regression model suggest age, subscapular measures, triceps folds, 
LDL cholesterol, triglycerides, leptin levels and vitamin D intake appear to be the strongest 
predictors in leptin variation. This model suggests approximately 26.5% of adiponectin 
variation could be explained by these variables (F = (7, 61) = 3.14) (p = 0.007). Leptin 
variation in men was most significantly influenced by BMI (β = 0.314, p = 0.058), waist 
adiposity (β = 0.292, p = 0.166), subscapular adiposity (β = 0.219, p = 0.029) and 


















Df1 Df2 Sig F 
Change 
1 0.515 0.265 0.181 0.4932 0.265 3.148 7 61 0.007 
 
Leptin in Women 
Variation in average leptin between females was statistically significant (p = 
0.001). Result indicate age, subscapular, triceps, hip, waist and BMI measures, 
triglycerides and folate intake were the most significant variables in predicting leptin 
variation at 52.6% (F = (8, 73) = 10.1) (p < 0.001) in females. Female leptin variation was 
most significantly influenced by subscapular adiposity (β = 0.384, p = 0.011). 
 













Df1 Df2 Sig F 
Change 
1 0.725 0.526 0.474 0.4489 0.526 10.122 8 73 0.000 
 
Leptin in Men 
Variation in average leptin between males was statistically significant (p = 0.007).  
Using multiple linear regression, age, subscapular, triceps, hip, waist, wrist measures, 
BMI, adiponectin levels and vitamin D intake proved to be the strongest predictors of 
leptin, explaining 78.2% of its variation (F = (10, 58) = 20.8) (p < 0.001). Scaled to the 
same level, the variables with the greatest effect on adiponectin phenotypes in men were 
age2 (β = 0.326, p = 0.013), vitamin D (β = 0.018, p = 0.018), triglyceride lipids (β = -
0.308, p = 0.018) and subscapular adiposity (β = -0.358, p = 0.037). 
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 There are relatively few studies examining dietary intake and adiponectin and 
leptin hormone levels. The goal here was to investigate the associations between 
nutritional intake values and measures of hormone levels relative to adipose within a 
representative Mennonite sample population. This study suggests a complex relationship 
between dietary vitamin D and adipokine concentrations in a representative sample 
population of Kansas Mennonite. Findings are nutrient-specific and sex-specific. Vitamin 
D intake was statistically significant in predicting adiponectin and leptin variation in men 
but not women. Folate is also a UV sensitive nutrient and its intake was statistically 
significant in determining leptin levels in women but not in men. Adiponectin influences 
leptin variation and leptin influences adiponectin variation in men but not women. 
Findings validate existing works supporting a hypothesis of vitamin D as a determinant of 
biomarkers relevant to chronic disease risk (Bidulescu et al., 2014; Lee et al., 2007; 
Yannakoulia et al., 2003). 
Mennonite communities have traditionally observed largely agricultural lifestyles 
and practices of endogamy, marrying within their church groups as means to maintain 
degrees of cultural and political isolation. These features of the Mennonite communities 
increase the probability and duration of time in UV light and suggests a holistic nutritional 
context distinct from the nutritional and dietary habits and beliefs of the greater U.S. 
Through practice of endogamy, genealogical records and general isolation the communities 
have greater similarities on a population level than a random heterogeneous U.S. sample. 
Previous research on nutrition and chronic disease risk has not controlled for 
heterogeneous sampling, limiting the ability to make population level conclusions and 
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implement operational change. The communities represented here still observe strict non-
smoking and non-alcohol drinking practices, both of which influence the biological 
variables collected for this study. These cultural features remove both confounders which 
are otherwise frequently seen in the general U.S. population. The church groups in this 
thesis are believed to have lost a degree of genetic isolation as a result of increase gene 
flow into these populations (Melton, 2010; Crawford, 2000). 
The relationships between nutritional intake on adiponectin and leptin levels 
provide enhanced means to study the interactions between human health and changes in 
the nutritional environment. This study may highlight a need for refined nutritional 
quantification methodologies for epidemiological studies as well as ideal population 
dynamics in which to test nutritional epidemiological questions regarding intake and 


























   
Chronic diseases are the leading cause of death and all-cause mortality in the world 
(WHO, 2014). Their increasing prevalence has resulted in the decrease in overall healthy 
life-years experienced within developed and developing countries (Farder, 2014). Chronic 
diseases are often lifelong once they develop, becoming more common and persistent with 
time. Age-related diseases are believed to be evolutionary trade-offs of the human lifespan; 
the longest of all primates. These extraordinary lifespans are the results of the conscious 
improvement of the human environment (Finch, 2010). Through the cultural enhancement 
of group behaviors, food quality and production, antibiotic and viral medicines, we saw 
reduction and ultimate removal of many sources of early life mortality. Unique to humans 
is also the ubiquitous lifespan advantage of one sex, with women on average living longer 
than men. Instances of focused environmental stress or insult however, such as nutritional 
deficiencies, accelerate and cause the developmental manifestation of chronic disease. 
A superficial digital survey of US medical schools’ curricula makes apparent the 
absence of certain topics. Evolutionary theory and its relevance for clinicians are usually 
not discussed.  There is also little education about diet, sex-specific phenotypic diversity 
and how both impact pathological trajectories and health outcomes (Adams et al., 2006; 
Adams et al., 2010a; Adams et al., 2010b; Winick, 1993). Most unfortunate is the 
ignorance of the importance of diet. U.S. doctors unfortunately receive little to no 
nutritional training in their formative years of medical school; traditional allopathic 
training focuses on anatomy and physiology.  (Frantz et al., 2011; Lenders et al., 2013). 
Doctors and health practitioners are often incapable of counselling or advising on personal 
health complications or management strategies in nutritional contexts, forcing patients to 
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seek out alternative health expertise that are otherwise socio-politically and bio-medically 
stigmatized. Unfortunately, physicians are overwhelmed with many demands on their time 
starting in medical school. There is also much emphasis on ethics, health care system 
navigation, being culturally competent and thinking critically during diagnosis. These 
curricular shortcomings are not likely to be remedied.  
Despite evidence illustrating nutrition’s direct role modulating chronic disease 
phenotypes, proximate explanations and mechanisms lack clarity (Gibney et al., 2014). 
Research in nutritional management of chronic disease risk and MetS is confounded by 
subpopulation factors and high bio-social heterogeneity within populations (Bidulescu et 
al., 2014; Kuo, 2015; Liu et al., 2009). As pharmaceutical industries continue to expect 
leveraging information from the Human Genome Project in novel drug development, the 
food industry is equally able to position nutrition and functional foods to promote health 
and prevent disease (Gillies, 2003). It should be noted however that epigenetic and 
nutrigenetic responses to chronic disease and individual health are not without public and 
scholarly critique (Heijmans and Mill, 2012; Saukko et al., 2010).  
 
Nutrition in Disease Risk Management 
Most the world is malnourished, either due to overconsumption of calories or as a 
function of ignorance or poverty regarding nutritional deficits (Foss, 2009; Via, 2012; 
Westerterp, 2013). Another challenge for allopathic physicians is the shift from infectious 
disease to rapidly escalating rates of chronic diseases and the pathologies associated with 
MetS. Understanding that nutrition directly impacts one’s wellbeing and genetics it is 
vexing to see many U.S. doctors and healthcare professionals receive little to no nutritional 
education and training in their formative years of schooling (Frantz et al., 2011; Lenders et 
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al., 2013). This is likely a product of the social movement among physicians and doctors in 
resisting evidence based medicine; the medical practice of applying research evidence to 
medical practice (Pope, 2003). An analysis of this phenomena within a critical social or 
medical anthropological framework may prove beneficial in designing nutritional 
interventions and treatments to chronic disease at both the population and individual levels 
separately.  
Nutritional counselling and therapy strategies are foreign to allopatric and Western 
physicians. This is likely a product of the social movement among physicians and doctors 
in resisting evidence based medicine; the medical practice of applying research evidence to 
medical practice (Pope, 2003). The neglect of nutrition is unfortunate and frustrating 
considering most the world is malnourished, either due to overconsumption of too many 
calories or as a function of either ignorance or poverty regarding nutritional deficits (Foss, 
2009; Via, 2012; Westerterp, 2013). Additionally, there is a shift in disease patterns of the 
US with infectious disease having been replaced by chronic conditions. Poor diet and 
physical health lead to obesity and associated comorbidities as hypertension, 
cardiovascular disease, diabetes and obesity. Successful application of nutrition in health 
and disease management may be possible with the concept of personalized nutrition; using 
individual genetics to help determine individual nutritional recommendations 
(Konstantinidou et al., 2014; Matthys et al., 2014). Additionally, changes in behavioral 
routines and lifestyle have been shown to improve adipokine levels in obese and diabetic 
patients (Monzillo et al., 2003). 
The obvious dimorphism of chronic health and individual variation in health traits 
make it a necessity to examine fundamental social and biological elements (Goldman et al., 
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2004). Investigating disease where genes and environment interact to create them requires 
consideration of both the social and environmental contexts in which they persist as well as 
the biomedical mechanisms underlying them (Chakravarthy et al., 2008; Naukkarinen et 
al., 2012; Neel, 1962; Odling-Smee, 2003; Prentice et al., 2005; Speakman, 2008). Gene-
environment interactions between nutrition and lifestyle contribute to the differences and 
variations in human health outcomes and physiology (Kaput, 2016). Developing risk-
benefit factors must be completed within the individual contexts of food complexity, 
genetic diversity, life-history experience, cultural narratives and lifestyle and variety of 



















Adipocyte: A fat cell, adipocytes are the cells which make up adipose tissue. There are 
several different kinds of adipocytes which determine what kind of adipose tissue is being 
expressed. There are white, brown and beige or brite adipocytes and therefore adipose 
tissue as well. 
 
Adipogenesis: The biological process that produces new fat cells. This processes is either 
promoted or inhibited by internal and external environmental signals, lifestyle, nutritional 
status and genetics.  
 
Adipokine: A specific class of hormone that is primarily but not necessarily exclusively by 
adipose tissue. Adipokines are powerful signaling molecules that communicate with and 
respond to changes in the body. Some adipokines require both nervous and endocrine 
systems to work, adiponectin and leptin are two examples of these.   
 
Adiponectin: A hormone that is secreted by adipose tissue which is anti-inflammatory, 
insulin sensitizing and neuroprotective. A person’s adiponectin levels are often lower than 
average in some chronic disease states. 
 
Adipose Tissue: One of the organs in the endocrine system. Adipose tissue helps maintain 
the all other bodily systems. Adipose tissue is highly responsive to environmental stress, 
helping maintain energy homeostasis throughout the life. Humans, relative to all other 
animals, have a lot of adipose tissue 
 
Adiposity: The individual body fat content and body fat pattern made by adipose tissue 
expression and deposition. An individual’s adiposity determines the chronic diseases that 
follow after development of obesity. Adiposity works under influence from age, sex, 
nutrition and environmental exigencies.   
 
C/EBP: Short for CCAAT enhancing binding protein. C/EBP is a specialized protein 
referred to as a transcription factor which regulates genetic expression and proliferation of 
new adipocytes.  
 
Chronic disease: Chronic diseases – i.e. heart disease, stroke, obesity, diabetes, cancer- 
are the most common, costly and preventable of all health problems. Yet, chronic diseases 
are also greatest cause of death worldwide.  
 
Dimorphism: Dimorphism or sexual dimorphism refers to the distinction between a male 
and female members of the same species. The differences in traits can include variations in 
size, color, shape or even structures. These differences are from the inheritance sexual 
pattern from one’s genetic.  
 
Epidemiology: The field of medicine that is concerned with the spread, prevalence and 




Epigenetics: The study of how genes are turned on or off by environmental signals. These 
gene-envrionment interactions can influence health and wellbeing. Contributing factors in 
individual epigenetic variation includes nutrition, age, chemical that interrupt or block 
biological processes, climate, geography, migration, culture and language. The magnitude 
of influence these forces have on a person’s epigenetics is spatiotemporally relative.  
 
Gene: A stretch of DNA molecule that codes for important proteins and enzymes. Some 
genes are larger than others and can be present in different forms (polymorphism).  
 
Genetic expression: When the product of a genetic code is produced.  
 
Genetic Epidemiology: The field of epidemiology that takes advantage of genetic 
information and methods in understanding disease risk and incidence. Particularly useful 
and applicable when examining complex traits and chronic disease.  
 
Hormone: A molecule that carry chemical signals throughout the body which 
communicate stimuli from changes in internal and external environments. Organs which 
play significant roles in hormone homeostasis, such as adipose, are part of the endocrine 
system. 
 
Integumentary: The one of the many body’s organ systems, is comprised of the skin and 
all of its adjuncts. This system includes hair, nails, hooves, feathers and scales in general 
biology.  
 
Isomerization: A chemical process that occurs when one molecule transforms into another 
by rearranging the order of its elements, not by adding or removing additional ones. When 
vitamin D is produced in the skin, the compound that becomes vitamin D3 undergoes an 
isomerization processes before being transported out of the skin cell.  
 
Lipophilic: A term used to describe something that binds to or dissolves in lipids. Vitamin 
D is lipophilic, meaning it bind to lipids when it is complete and dissolves in them when 
active.  
 
Metabolic syndrome: Described as a constellation like pathology, the metabolic syndrome 
is the combined occurrence of several chronic diseases typically associated to energy 
homeostasis and metabolism. Obesity is the greatest risk factor.  
 
Nutrigenetics: A field of epigenetics that studies how diet and genetics interact. Gene-
nutrient interactions may silence or express individual genes, modify cellular behavior and 
homeostasis and impact bodily health and wellbeing.  
 
PPAR: Short for peroxisome proliferator-activated receptor. PPAR, like C/EBP, is an 






Appendix and Supplementary 
 
Notations used in construction of the triad in nutritional methodologies (methods chapter): 
 
r = Sample correlation 
p = Validity coefficient 
A = Intake measured using questionnaire answers 
B = Intake measured using 24-dietary memory recall 
C = Intake measured using laboratory biochemical methods 
T = Estimation of true intake of nutrient  
 
rAB = pat · pBT                  pAT = √ ((rAB · rCA) / (rBC)) 
rBC = pBT · pCT                   pBT = √ ((rAB · rBC) / (rCA)) 
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